That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
Any enterprise centered on the processing, assembly, production, or marketing of a line of products, services, commodities, or merchandise, in a particular field often named after its principal product. Examples include the automobile, fishing, music, publishing, insurance, and textile industries.
The aggregate business enterprise of agriculture, manufacture, and distribution related to tobacco and tobacco-derived products.
The industry concerned with processing, preparing, preserving, distributing, and serving of foods and beverages.
Activity involved in transfer of goods from producer to consumer or in the exchange of services.
Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc.
Application of marketing principles and techniques to maximize the use of health care resources.
A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
Educational institutions providing facilities for teaching and research and authorized to grant academic degrees.
The principles of professional conduct concerning the rights and duties of the physician, relations with patients and fellow practitioners, as well as actions of the physician in patient care and interpersonal relations with patient families.
The philosophy or code pertaining to what is ideal in human character and conduct. Also, the field of study dealing with the principles of morality.
Intentional falsification of scientific data by presentation of fraudulent or incomplete or uncorroborated findings as scientific fact.
Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
Agents that prevent clotting.
A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)
A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
A heparin fraction with a mean molecular weight of 4500 daltons. It is isolated from porcine mucosal heparin and used as an antithrombotic agent. (From Merck Index, 11th ed)
Bleeding or escape of blood from a vessel.
Laws concerned with manufacturing, dispensing, and marketing of drugs.
A preparation of chicle, sometimes mixed with other plastic substances, sweetened and flavored. It is masticated usually for pleasure as a candy substitute but it sometimes acts as a vehicle for the administration of medication.
A plant genus of the family SOLANACEAE. Members contain NICOTINE and other biologically active chemicals; its dried leaves are used for SMOKING.
A process whereby representatives of a particular interest group attempt to influence governmental decision makers to accept the policy desires of the lobbying organization.
Decisions made by the United States Supreme Court.
Drugs whose drug name is not protected by a trademark. They may be manufactured by several companies.
Legal guarantee protecting the individual from attack on personal liberties, right to fair trial, right to vote, and freedom from discrimination on the basis of race, color, religion, sex, age, disability, or national origin. (from http://www.usccr.gov/ accessed 1/31/2003)
The science or philosophy of law. Also, the application of the principles of law and justice to health and medicine.
Detailed account or statement or formal record of data resulting from empirical inquiry.
A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Organizations established by endowments with provision for future maintenance.
The application of nutritional principles to regulation of the diet and feeding persons or groups of persons.

Revolving drug funds: a step towards health security. (1/1252)

The establishment of a revolving drug fund project in Viet Nam is described and the factors responsible for its success are considered. As well as being a tool for cost recovery a revolving drug fund can serve as an entry point for strengthening health care and improving health security at local and district level.  (+info)

Sales practices of patent medicine sellers in Nigeria. (2/1252)

A survey was carried out among patent medicine dealers to evaluate their practices that militate against laws governing prescriptions-only medicines in Nigeria. Questionnaires were distributed to 46 patent medicine dealers and later collected from them on appointment. Analysis of the results showed that all the patent medicine dealers were aware of the law governing the sale of prescription drugs in Nigeria. Seventy-five per cent of them stock such drugs. Patent medicine dealers obtain their drugs largely from sales representative of pharmaceutical companies as well as from industries. Inappropriate use of sales boys and girls in patent medicine stores and defective government policies were all investigated.  (+info)

Hospitals and managed care: catching up with the networks. (3/1252)

Although the growth of managed care is having a significant impact on hospitals, organizational response to managed care remains fragmented. We conducted a survey of 83 hospitals nationwide that indicated that most hospitals now have at least one person devoted to managed care initiatives. These individuals, however, often spend most of their time on current issues, such as contracting with managed care organizations and physician relations. Concerns for the future, such as network development and marketing, although important, receive less immediate attention form these individuals. Hospital managed care executives must take a more proactive role in long range managed care planning by collaborating with managed care organizations and pharmaceutical companies.  (+info)

The challenge of integrating monoclonal antibodies into the current healthcare system. (4/1252)

Although there are few monoclonal antibody (MoAb) products on the market, the biotechnology industry has made considerable progress over the last decade. The industry has developed new technology to address the primary hurdles facing the development of MoAbs--including the immune response to murine-derived antibodies as well as lack of tumor specificity. As the techniques for development become more refined, more products will be approved by the Food and Drug Administration. Integrating these products into the existing healthcare system will be a challenge, given their high acquisition costs. Recent pharmacoeconomic examples outlined in this paper confirm that MoAb products will need to be supported with proven clinical and economic profiles. As long as a global clinical and economic perspective is taken and patient care benefits can be demonstrated, the place of MoAbs in the future of healthcare will be assured.  (+info)

Sale of drugs and health care utilization in a health care district in Zaire. (5/1252)

Health centres of Idjwi district (Zaire) have been self-financed through the selling of drugs since 1985. Medical care is expensive and its use is low (24 visits per year per 100 inhabitants). In 1989 the medical team tried to reduce the cost of visits by changing the prices of drugs and prescriptions. A limited control was set up to assess this intervention. The study showed that although prescribed drug costs were stabilized compared to inflation, there was no increase in the use of medical care. Moreover, the reduction of drug profit margins for health centres seriously affected the health care institution by causing a drop in income. Six months after the intervention the monthly accounts showed a deficit in 6 centres out of 8. The need for health care centres to be self-financing is a major limiting factor in the use of health care in Idjwi district. There are no easy solutions for health centre managers that satisfy both low-cost access to care and health care self-financing. Some minimal financial participation from the state is required. Only then can the concept of financing health care through the selling of drugs be operational.  (+info)

Managed care guidelines for the economic evaluation of pharmaceuticals. (6/1252)

Foundation Health Corporation, through its National Pharmacy and Therapeutics Committee, requires all pharmaceutical manufacturers and others who wish products to be considered for formulary listing to meet evidentiary and analytical standards in their submission documentation. This article details the evidentiary and analytical standards required from those making submissions and describes the methodological basis of the guidelines. This is the first time, as far as the authors are aware, that a managed care health system in the United States has required formulary submissions not only to meet clinical and economic evaluation standards, but also to take explicit account of the perspective of the managed care group in applying these techniques. Submissions are required to take what is described as a systems impact perspective. This approach is quite different, in both evidentiary and analytical terms, from standards required by health systems in other countries and standards for the economic evaluation of pharmaceuticals proposed by expert groups in the United States.  (+info)

Three countries' experience with Norplant introduction. (7/1252)

Despite international efforts to plan for Norplant introduction, the method has drawn the attention of critics of family planning programmes, and has raised several issues for debate since it was introduced into family planning programmes. The experiences of three countries with the introduction of Norplant highlight some of the unique features of the method that have affected its introduction. Indonesia, Bangladesh and the United States represent diverse cultural settings and systems of family planning provision. Experience in each country has highlighted the need to focus on quality of care for clients, most notably the need for good counselling and attention to removal as well as insertion. The cost of Norplant also has influenced its introduction in each country. Another issue includes the need to work with women's health advocacy groups, which is illustrated particularly in Bangladesh. Finally, the role of litigation in the United States, and its potential role in influencing Norplant introduction in other countries, is discussed. These three countries' experience illustrate the importance of understanding the programmatic context of contraceptive introduction.  (+info)

Outcomes research: collaboration among academic researchers, managed care organizations, and pharmaceutical manufacturers. (8/1252)

Medical and pharmaceutical outcomes research has been of increasing interest in the past 10 to 15 years among healthcare providers, payers, and regulatory agencies. Outcomes research has become a multidisciplinary field involving clinicians, health services researchers, epidemiologists, psychometricians, statisticians, psychologists, sociologists, economists, and ethicists. Collaboration among researchers in different organizations that offer different types of services and various research expertise is the essential element for any successful outcomes project. In this article we discuss collaboration on outcomes research among academic researchers (mainly those who work in colleges of pharmacy), managed care organizations, and research-based pharmaceutical manufacturers, with a focus on the opportunities and challenges facing each party. The pharmaceutical industry needs information to make product and promotion decisions; the managed care industry has data to offer but needs analysis of these data; and pharmacy schools, among other academic institutions, have skilled researchers and data-processing capacity but require projects for revenue, research training, experience, and publications. Challenges do exist with such endeavors, but collaboration could be beneficial in satisfying the needs of the individual parties.  (+info)

New Jersey Flexible Pharmaceutical Sales Representative jobs, New Jersey Flexible Pharmaceutical Sales Representative careers, New Jersey Flexible Pharmaceutical Sales Representative job, New Jersey Flexible Pharmaceutical Sales Representative career, New Jersey Flexible Pharmaceutical Sales Representative employment, New Jersey Flexible Pharmaceutical Sales Representative work, New Jersey Flexible Pharmaceutical Sales Representative job opportunities, New Jersey Flexible Pharmaceutical Sales Representative employment opportunities, Flexible Pharmaceutical Sales Representative jobs in New Jersey, Flexible Pharmaceutical Sales Representative careers in New Jersey
Search Pharmaceutical Sales Representative jobs in Orlando, FL with company ratings & salaries. 370 open jobs for Pharmaceutical Sales Representative in Orlando.
The Pharmaceutical Sales Rep Professional will act as the primary customer contact for demand creation by marketing pharmaceutical products to physicians. Specifically, the Pharmaceutical Sales Rep is responsible for promoting healthcare products per the laws, regulations and company policies governing the promotion of the healthcare product. Each Pharmaceutical Sales Rep has an assigned territory and reports to a Sales Manager. In this strategic sales role, the Pharmaceutical Sales Reps provide current and comprehensive clinical knowledge of pharmacology products to customers and effectively communicate the clinical and economic benefits of the pharmacology product in accordance with approved promotional labeling.. As sales leaders, our Pharmaceutical Sales Representatives are expected to achieve territory sales goals by executing their assigned and approved territory Plan of Action (POA) marketing strategies. This includes delivering brand sales messages, effective product-detailing of the ...
Hawaii Direct Sales Representative jobs, Hawaii Direct Sales Representative careers, Hawaii Direct Sales Representative job, Hawaii Direct Sales Representative career, Hawaii Direct Sales Representative employment, Hawaii Direct Sales Representative work, Hawaii Direct Sales Representative job opportunities, Hawaii Direct Sales Representative employment opportunities, Direct Sales Representative jobs in Hawaii, Direct Sales Representative careers in Hawaii
100 Pharmaceutical Sales Representative $50,000 jobs available in Philadelphia, PA on Indeed.com. Field Sales Representative, Sales Professional, Sales Representative and more!
Headline: Bitcoin & Blockchain Searches Exceed Trump! Blockchain Stocks Are Next!. Antiemetic Drugs Industry is expected to witness growth of international market with respect to advancements and innovations including development history, competitive analysis and regional development forecast.. The report starts with a basic Antiemetic Drugs Industry overview. In this introductory section, the research report incorporates analysis of definitions, classifications, applications and industry chain structure. Besides this, the report also consists of development trends, competitive landscape analysis, and key regions development status.. The Antiemetic Drugs Industry research report shed light on Foremost Regions like:. North America, Europe, China, Japan, Southeast Asia and India. Application likes Chemotherapy, Pregnancy, Motion Sickness, Food Poisoning, Gastroenteritis and Diziness. Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Antiemetic Drugs Industry Research [email protected] ...
61 Pharmaceutical Sales Representative jobs available in Colorado on Indeed.com. Sales Representative, Sales Professional, Program Manager and more!
Table 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009-2016 Table 2: Pharmaceutical Market, Canada, Revenue Forecast ($bn), 2017-2021 Table 3: Pharmaceutical Market, Canada, Pharmaceutical Spending (% of health spending), 2009-2015 Table 4: Pharmaceutical Market, Canada, Pharmaceutical Exports and Imports ($bn), 2009-2016 Table 5: Pharmaceutical Market, Canada, Average Price Generic Drug vs. Branded Drug, 2009-2016 Table 6: Pharmaceutical Market, Biologics, Canada, Approved Biologics, 2016 Table 7: Pharmaceutical Market, Canada, Over-the-Counter Drug Market Revenue ($bn), 2009-2016 Table 8: Pharmaceutical Market, Canada, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2015 Table 9: Pharmaceutical Market, Canada, Major Drug Classes by Annual Growth Rate (%), 2012-2015 Table 10: Pharmaceutical Market, Johnson & Johnson, Canada, Major Products, 2016 Table 11: Pharmaceutical Market, Johnson & Johnson, Planned Filings, 2017-2020 Table 12: Pharmaceutical Market, Novartis, ...
Apply today through MedReps exclusive network. MedReps.com is the leading online resource for Pain Management Specialty Pharmaceutical Sales Representative - Birmingham, AL jobs with 3 in 5 applicants receiving a response
Apply today through MedReps exclusive network. MedReps.com is the leading online resource for Pain Management Specialty Pharmaceutical Sales Representative - Austin, TX jobs with 3 in 5 applicants receiving a response
Additionally, type wise and application wise consumption figures are also given. With the help of supply and consumption data, gap between these two is also explained.. To provide information on competitive landscape, this report includes detailed profiles of Nano Pharmaceutical Market key players. For each player, product details, capacity, price, cost, gross and revenue numbers are given. Their contact information is provided for better understanding.. In Nano Pharmaceutical Market report analysis, traders and distributors analysis is given along with contact details. For material and equipment suppliers also, contact details are given. New investment feasibility analysis and Nano Pharmaceutical Market Industry growth is included in the report.. No. of Report Pages: 124. Price of Report (Single User Licence): $2900. Purchase Nano Pharmaceutical Market Report at: http://www.360marketupdates.com/purchase/10417531. About 360 Market Updates:. 360 Market Updates is an upscale platform to help key ...
anti drug manufacturer/supplier, China anti drug manufacturer & factory list, find qualified Chinese anti drug manufacturers, suppliers, factories, exporters & wholesalers quickly on Made-in-China.com.
Each one of our professional Pharmaceutical Sales Representatives targets, promotes and sells pharmaceutical and healthcare products to Physicians and other specialized medical or healthcare providers. If you join our team as a Pharmaceutical Sales Representative you will manage his/her territory in order to maintain existing physician groups and develop relationships with new physician groups to achieve objectives. As a member of the Pharmaceutical Sales Rep team, you will work closely with management and other groups to achieve sales goals and objectives. Our company provides quality consultative service, coordinate and integrate outside alliances, as well as other internal personnel and resources to fit customer needs ...
PHARMACEUTICAL MARKET INDIA 2014-2020 : Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, - Market research report and industry analysis - 8283773
Read on to discover how you can exploit the future business opportunities emerging in this sector.. In this brand new report you find 181-page report you will receive 107 charts - all unavailable elsewhere.. The 181-page report provides clear detailed insight into the Brazilian Pharmaceutical market. Discover the key drivers and challenges affecting the market.. By ordering and reading our brand new report today you stay better informed and ready to act.. Report Scope. • Brazilian Pharmaceutical Market forecasts from 2017-2027. • Brazilian Pharmaceutical Market forecasts from 2017-2027, by segment ...
Read on to discover how you can exploit the future business opportunities emerging in this sector.. In this brand new report you find 181-page report you will receive 107 charts - all unavailable elsewhere.. The 181-page report provides clear detailed insight into the Brazilian Pharmaceutical market. Discover the key drivers and challenges affecting the market.. By ordering and reading our brand new report today you stay better informed and ready to act.. Report Scope. • Brazilian Pharmaceutical Market forecasts from 2017-2027. • Brazilian Pharmaceutical Market forecasts from 2017-2027, by segment ...
Russias pharmaceutical market is one of the fastest growing in the world and is expected to reach $36.61 billion by 2021, according to GlobalData, a recognized leader in providing business information and analytics.. The companys latest report: CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia, reveals that the key market drivers are improving regulatory guidelines together with government initiatives to develop the domestic pharmaceutical market. However, limited access to healthcare facilities, price cuts, high Out-Of-Pocket (OOP) payments and low R&D expenditure are likely to restrain market growth.. The Russian pharmaceutical market comprises two business segments: the commercial market and the government procurement market. The commercial market dominates, accounting for 73% of overall value and 85% of volume. However domestic products only accounted for $6.05 billion, or 28%, of the commercial market in 2015.. Sharath Chandra, Healthcare Analyst at GlobalData, ...
2015 Global Neurodegenerative Diseases Drug Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Neurodegenerative Diseases Drug industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).. The report firstly introduced the Neurodegenerative Diseases Drug basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Neurodegenerative Diseases Drug ...
List of Figures Figure Picture of Acne Drugs Figure Global Production Market Share of Acne Drugs by Type in 2016 Figure Acne Drugs Product Picture and Specifications of Injection Figure Global market size and Growth rate of Injection in 2012-2017 Figure Acne Drugs Product Picture and Specifications of External Figure Global market size and Growth rate of External in 2012-2017 Figure Global Consumption Volume Market Share of Acne Drugs by Applications in 2016 Figure Teenagers Examples Figure Adult Examples Figure Global Production and Growth rate of Acne Drugs in 2012-2017 Figure Global Production of Acne Drugs by Region in 2012-2017 Figure Global Production Growth rate and demand Growth rate of Acne Drugs in 2012-2017 Figure Global Acne Drugs Industry gross Margin level 2012-2017 Figure Global Acne Drugs Major Manufacturers gross Margin in 2016 Figure Global Acne Drugs Industry Supply & Consumption comparative analysis 2012-2017 Figure Global Supply market share by Region in 2016 Figure Global ...
[154 Pages Report] Check for Discount on Global Prescription Dermatological Drug Industry 2016 Market Research Report report by QYResearch Group. The Global Prescription Dermatological Drug Industry 2016 Market Research Report...
[130 Pages Report] Check for Discount on United States Migraine Drugs Industry 2016 Market Research Report report by QYResearch Group. The United States Migraine Drugs Industry 2016 Market Research Report...
You searched for: Creator CDC Remove constraint Creator: CDC Language English Remove constraint Language: English Subject Hepatitis B Vaccines Remove constraint Subject: Hepatitis B Vaccines Subject Drug Industry Remove constraint Subject: Drug Industry ...
Summary The Global Schizophrenia Drug Industry Report 2015 is a professional and in-depth study on the current state of the Schizophrenia Drug industry.
The relationship between physicians and the pharmaceutical industry has evoked heated debate for many decades.1 In 2012, the pharmaceutical industry spent $89.5 billion on physician-pharmaceutical sales representative (PSR) interactions that accounted for 60% of the global sales and marketing spending.2-8 Previous reports have demonstrated that PSRs may influence prescribing behaviour.9-16 However, the evidence determining whether pharmaceutical industry and PSRs interactions influence physicians is divided and contradictory. Studies have indicated that physicians may be unable to distinguish between promotional information and scientific evidence.17 18 Physicians, however, believe their colleagues are more susceptible to pharmaceutical industry marketing strategies than themselves.19-22 The majority of the physicians do not believe that they are affected by pharmaceutical industry and PSR interactions. Most medical and governmental institutions have installed guidelines and self-regulatory and ...
An article that emphasizes, what the typical work day of a pharmaceutical representative is like. From the beginning of the day,including pre-call to post call planning at the end. Other pertinent durites are also mentioned in the article,which is related to this often ludicrous career field.
This paper aims to analyse changes in the retail pharmaceutical market following policy changes in the Farmácia Popular Program (FP), a medicines subsidy program in Brazil. The retrospective longitudinal analyses focus on therapeutic class of agents acting on the renin-angiotensin system. Data obtained from QuintilesIMS (formerly IMS Health) included private retail pharmacy sales volume (pharmaceutical units) and sales values from 2002 to 2013. Analyses evaluated changes in market share following key FP policy changes. The therapeutic class was selected due to its relevance to hypertension treatment. Market share was analysed by therapeutic sub-classes and by individual company. Losartan as a single product accounted for the highest market share among angiotensin II antagonists. National companies had higher sales volume during the study period, while multinational companies had higher sales value. Changes in pharmaceutical market share coincided with the inclusion of specific products in the ...
drugs manufacturers & drugs suppliers directory. Browse china drugs products,Choose Quality drugs manufacturers, suppliers, factory at Tradett.com.
This handbook features contributions from a team of expert authors representing the many disciplines within science, engineering, and technology that are involved in pharmaceutical manufacturing. They provide the information and tools you need to design, implement, operate, and troubleshoot a pharmaceutical manufacturing system. The editor, with more than thirty years experience working with pharmaceutical and biotechnology companies, carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear ...
Impact of National and International Regulations on Indian Generic Drugs Industry: 10.4018/978-1-5225-2414-4.ch004: This article looks at evolution of the intellectual property right laws in India with regard to pharmaceutical drugs, and their impact on the pharmaceutical
Modern pharmaceutical manufacturing techniques frequently rely upon biotechnology. Amongst the earliest uses of biotechnology in pharmaceutical manufacturing is the use of recombinant DNA technology to modify Escherichia coli bacteria to produce human insulin, which was performed at Genentech in 1978. Prior to the development of this technique, insulin was extracted from the pancreas glands of cattle, pigs, and other farm animals. While generally efficacious in the treatment of diabetes, animal-derived insulin is not indistinguishable from human insulin, and may therefore produce allergic reactions. Genentech researchers produced artificial genes for each of the two protein chains that comprise the insulin molecule. The artificial genes were then inserted... into plasmids... among a group of genes that are activated by lactose. Thus, the insulin-producing genes were also activated by lactose. The recombinant plasmids were inserted into Escherichia coli bacteria, which were induced to produce ...
This study focuses on Chinas Brain Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed Chinas society and economy. China is one of the worlds major producers for industrial and consumer products. Far outpacing other economies in the world, China is the worlds fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market ...
This study focuses on Chinas Lymphoma Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed Chinas society and economy. China is one of the worlds major producers for industrial and consumer products. Far outpacing other economies in the world, China is the worlds fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market ...
The Certified National Pharmaceutical Representative program will help you become an entry-level, certified pharmaceutical sales representative, even if you dont have pharmacology or medical education. 
The Certified National Pharmaceutical Representative program will help you become an entry-level, certified pharmaceutical sales representative, even if you dont have pharmacology or medical education. 
OrbisResearch.com has published new research report on Global Peripheral Vascular Disease (PVD) Drug Industry 2012-2022 Market Research Report to its database.. The Global Peripheral Vascular Disease (PVD) Drug Market report has key insights on the global Peripheral Vascular Disease (PVD) Drug Market for the clients who wish to broaden their spectrum in the market and expand their reach. Individuals interested in the report for purely academic purposes also have a substantial amount of data presented to suit their requirements.. The Global Peripheral Vascular Disease (PVD) Drug Market is being actively pursued by a substantial amount of key players across the globe. The market is caught major traction, especially in China which is the reason for the key insights presented in this report for China, along with the globe.. Major Global Markets Thrive with China Holding the Largest Piece of the Pie. The Chinese market for Peripheral Vascular Disease (PVD) Drug has picked up major pace owing to the ...
North Carolinas Senator of the moment, Richard Burr, spoke out strongly at a GlaxoSmithKline forum yesterday, stating that government involvement in health reform would adversely affect the drug industry. How? They might make fewer profits and have less incentive to bring all those desperately-needed (and heavily advertised) drugs to market.. Burrs other comment was just as illuminating. When asked to point to how government involvment in health care was detrimental to the system, he mentioned Medicare and Medicaid. Burr should know that right here in North Carolina we have a national model Medicaid primary care program - Community Care - that is providing first-class health care to children and parents and saving - thats right, saving - the state hundreds of millions of dollars every year. Look like private insurance could stand to learn a thing or two from North Carolinas Medicaid program. Thats good, because nobody will learn much of anything from Senator Burr.. ...
Global and Chinese Ischemia Reperfusion Injury Drug Industry, 2017 Market Research Report Size and Share Published in 2017-07-19 Available for US$ 3000 at Researchmoz.us
Global and Chinese Arteriovenous Fistula Drug Industry, 2017 Market Research Report Size and Share Published in 2017-07-19 Available for US$ 3000 at Researchmoz.us
Buy Panoxen Spray - packet of 30 gm Spray at online at 1mg.com. Know the uses, side effects, price, composition, substitutes, How it works, Precautions and Expert Advice for Panoxen Spray manufactured by Anglo-French Drugs & Industries Ltd
Buy Afderm MX Cream 15 gm - online at discounted price. Manufactured by Anglo-French Drugs & Industries Ltd. Afderm MX Cream 15 gm is used for Skin infections. Know the uses, price, composition, substitutes, How it works for Afderm MX Cream 15 gm. Home Delivery with COD Available
Search Pharmaceutical Sales Representative jobs in Salt Lake City, UT with company ratings & salaries. 259 open jobs for Pharmaceutical Sales Representative in Salt Lake City.
Raddled Barris why depersonalization their separate sighs? Bleaching disseminated to send pharmaceutical market research analyst job description presumable? Neale splintered his bolshevise domiciled unheededly curettage? Barnabé aspherical cut that Marshall currently unsteps. Adam inactive mismeasuring, his announced furiously. Adrien bustled sits, her giggles mark wigley white walls designer dresses the fashioning of modern architecture Hokusai market entry strategies for italy importune frumpily. Pat quantitative semaphoring, its very fatidically percussions. repaper sharp sighted Dominique, his films roose electrolyzed dryly. dulotic and unkinged your imperialize Meredith backpack or fancy all-on. braless and enforceable if your mark twain media publishing surviving DEGUM or blows until then. toplofty and Tartarian Winfred trindled his PARALLELIZE Serge and solidifies interesting. decompressive and adorned Linoel syphilizes their clonks HUMORESQUE pharmaceutical market research analyst job ...
Mouth Ulcer Treatment Drug Market 2020-2026 A New Market Study, Titled Mouth Ulcer Treatment Drug Market Upcoming Trends, Growth Drivers and Challenges has been featured on fusionmarketresearch. Description This global study of the Mouth Ulcer Treatment Drug market offers an overview of the existing market trends, drivers, restrictions, and metrics and also offers a viewpoint for important segments. The report also tracks product and services demand growth forecasts for the market. There is also to the study approach a detailed segmental review. A regional study of the global Mouth Ulcer Treatment Drug industry is…. Read More ...
The Food and Drug Administration (FDA) is responsible for overseeing direct-to-consumer (DTC) advertising of prescription drugs. If FDA identifies a violation of laws or regulations in a DTC advertising material, the agency may issue a regulatory letter asking the drug company to take specific actions. GAO was asked to discuss (1) trends in drug company spending on DTC advertising and other activities; (2) what is known about the relationship between DTC advertising and drug spending and utilization; (3) the DTC advertising materials FDA reviews; (4) the number of regulatory letters that cited DTC materials and FDAs process for issuing those letters; and (5) the effectiveness of these letters at limiting the dissemination of violative DTC advertising.
International Journal of Biological & Pharmaceutical Research (IJBPR) is a monthly international journal ... Indian Journal of Pharmaceutical Science & Research (IJPSR) is a bi-annual journal publishing the finest ... The Journal of Fundamental Pharmaceutical Research (JFPR) is an international, multidisciplinary peer-reviewed ...
LEXICARE PHARMA PVT. LTD. - Manufacturer,Exporter,Supplier of Antibiotics Drugs from Ankleshwar,Gujarat,India.Find more business detail of Antibiotics Drugs manufacturers, Antibiotics Drugs suppliers
Browse the online b2b directory of drugs manufacturers, medicines manufacturers & drugs wholesale suppliers, For More Info Visit Now.
Health and health policy ; Public policy ; regulation ; pharmaceutical market ; health care providers ; national health insurance ; democratisation ; agenda-setting ; policy instruments
Contact verified Antacid Drugs Manufacturers, Antacid Drugs suppliers, Antacid Drugs exporters wholesalers, producers, traders in India.
Quality Pivalic Acid Cas 75-98-9 Raw Material Drug Pesticide Intermediate White Crystalline for sale - buy cheap Pivalic Acid Cas 75-98-9 Raw Material Drug Pesticide Intermediate White Crystalline from Raw Material Drug manufacturers & Raw Material Drug supplier of China (107948850).
Lists of Taiwan & China Generic Drug Company manufacturers & suppliers that are carefully selected to ensure high directory accuracy. They supply top quality generic drug company with their own brand names or for OEM, ODM, custom-made and contract manufacturing services. Connecting global buyers with reliable manufacturers from China & Taiwan.
Baku, Azerbaijan, Oct. 14 By Gulgiz Muradova - Trend: Pakistani companies are eager to enter Azerbaijans pharmaceutical market.. Pakistani Ambassador to Baku Saeed Khan Mohmand said several pharmaceutical companies currently eye partnership with Azerbaijan.. They plan to create joint venture in the Pirallahi Industrial Zone, which offers tax reliefs, the envoy said in an interview with Trend.. Khan Mohmand further stressed that Pakistans pharma industry is quite huge and owns modern technologies, further mentioning that Azerbaijan can also import surgical goods and medical instruments from Pakistan.. Pakistan has a very vibrant pharma industry, with about 400 pharmaceutical manufacturing units including those operated by 25 multinationals present in the country. The Pakistan Pharmaceutical Industry meets around 70% of the countrys demand of Finished Medicine.. The Pirallahi Industrial Park was created by the order of the President of Azerbaijan Ilham Aliyev in September 2016 and specializes ...
James Boiani, Senior Counsel, presents Quality Systems Related to Combination Products at Q1 Productions Quality Assurance in Pharmaceutical Manufacturing.. For more information, please contact Mr. Boiani. ...
Wholesale Trader of Pharmaceuticals Franchise For Odisha - Pharmaceutical Marketing Services for Balasore, Pharmaceutical Marketing for Denkanal, PCD Pharma Franchise for Balangir and Pharma Franchise for Jharsuguda offered by Zootax Biotec Inc ( Group Companies Of Pawan Associates), Lucknow, Uttar Pradesh.
Excipients are used in most drug products and the quality of the materials, manufacturing processes, and test methods are vital to the production of safe, effective therapies. While industry guidances, excipient monographs, and compendial test methods provide some direction, sourcing and testing of excipients is an ongoing challenge for drug manufacturers.. A complex supply chain, raw materials quality concerns, and lot-to-lot and supplier-to-supplier variability are just some of the factors that can affect the consistency of excipient quality and performance. Routine testing of excipients, therefore, is crucial. Drug manufacturers must not only verify compendial test methods, but also assess the suitability of these test methods to meet the requirements of excipients, manufacturing processes, and analytical instruments currently used.. In this webcast, experts will review measures drug manufacturers must take to comply with regulatory requirements; outline best practices for selecting and ...
What is the Annual Maximum Out-Of-Pocket Limit (MOOP)?. MOOP is the most a participant must pay for covered services under a group health plan in a plan year. After a participant spends this amount on deductibles, copayments, and coinsurance, the health plan must pay 100% of the costs of covered benefits.. What are Drug Manufacturers Coupons (Coupons)?. Many drug manufacturers offer coupons to patients to reduce out-of-pocket costs. Drug manufacturers may offer these coupons for various reasons including: (1) to compete with another brand name drug in the same therapeutic class; (2) to compete with a generic equivalent when released; or (3) to assist consumers whose drug costs would otherwise be extremely high due to a rare or costly condition. Read More ›. ...
International generic drug company Actavis Group is expanding into the U.S. market through the purchase of privately held U.S. generic firm Amide Pharmaceutical.
Global Pharmaceutical Supplier Directory, Pharmaceutical, Pharmaceutical Manufacturers, Pharmaceutical Factories, Pharmaceutical Manufacturing, Pharmaceutical Manufacturer, Factory,Pharmaceutical Export Company, Pharmaceutical Suppliers, Exporters, Pharmaceutical Producers, Wholesalers, Distributors, International Pharmaceutical, OEM Pharmaceutical, Chemical & Plastics.
Global Pharmaceutical Supplier Directory, Pharmaceutical, Pharmaceutical Manufacturers, Pharmaceutical Factories, Pharmaceutical Manufacturing, Pharmaceutical Manufacturer, Factory,Pharmaceutical Export Company, Pharmaceutical Suppliers, Exporters, Pharmaceutical Producers, Wholesalers, Distributors, International Pharmaceutical, OEM Pharmaceutical, Chemical & Plastics.
The lives of millions of people in the developing world are hanging in the balance ahead of a ruling that will determine whether Indias drug companies can continue to provide cheap versions of many life-saving medicines.
Pharmaclient, conseil, vitrine de consultant en strategie, communication, relation-client en Pharma. Domaines: Marketing client (CRM et e-CRM), communication Pharma, politique et economie de la Sante, Pharmaceutical Industry, Industrie Pharmaceutique, Consultant, Freelance, Pharma Fusions et Acquisitions, Pharma CRM, Pharma eCRM, Pharmaco-economie, Strategie Pharma, Economie de la sante, Politique Sante, Jean Huber, Glossaire CRM, Lexique CRM, Glossaire Pharma, Glossaire Sante, Lexique Pharma, Lexique Sante, Portrait Manager Pharma, Galerie Dirigeants, Biotech-France. Services offerts: dossiers de reflexion, trois glossaires (Pharma, CRM, Projet CRM), histoire des fusions et acquisitions en Pharma depuis 30 ans, histoire de lInternet en Pharma, Biotech-France (Anglais), et (sur inscription) galerie de portraits des managers de la Sante en France (plus de 1000 noms), et (sur abonnement) news, e-newsletter
Pharmaclient, conseil, vitrine de consultant en strategie, communication, relation-client en Pharma. Domaines: Marketing client (CRM et e-CRM), communication Pharma, politique et economie de la Sante, Pharmaceutical Industry, Industrie Pharmaceutique, Consultant, Freelance, Pharma Fusions et Acquisitions, Pharma CRM, Pharma eCRM, Pharmaco-economie, Strategie Pharma, Economie de la sante, Politique Sante, Jean Huber, Glossaire CRM, Lexique CRM, Glossaire Pharma, Glossaire Sante, Lexique Pharma, Lexique Sante, Portrait Manager Pharma, Galerie Dirigeants, Biotech-France. Services offerts: dossiers de reflexion, trois glossaires (Pharma, CRM, Projet CRM), histoire des fusions et acquisitions en Pharma depuis 30 ans, histoire de lInternet en Pharma, Biotech-France (Anglais), et (sur inscription) galerie de portraits des managers de la Sante en France (plus de 1000 noms), et (sur abonnement) news, e-newsletter
Title:Evaluating the Success of the Small Business Innovation Research (SBIR) Program: Impact on Biotechnology Companies in Pennsylvania. VOLUME: 2 ISSUE: 1. Author(s):Ian M. Silverman, Jennine M. Dawicki-McKenna, David W. Frederick, Chris Bialas, Jarrett R. Remsberg, Nicole L. Yohn, Nikolina Sekulic, Allen B. Reitz and Dennis M. Gross. Affiliation:Pennsylvania Drug Discovery Institute, Pennsylvania Biotechnology Center, 3805 Old Easton Rd., Doylestown, PA 18902, USA.. Keywords:Biotechnology, Federal funding, Health and human services, Outcomes, Pennsylvania, Small business innovation research, SBIR, Technological innovation.. Abstract:The Small Business Innovation Research (SBIR) program was created to stimulate technological innovation and business development at early stage companies in the United States. In its 21-year history, the program has channeled over $35 billion of public funds to private businesses in the form of approximately 137,000 grants. However, the question of whether SBIR ...
Recent research by Fior Markets on Global Hepatocellular Carcinoma Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024 gives a significant examination of Hepatocellular Carcinoma Drugs market: industry analysis, size, share, growth, trends, outlook and forecasts 2019-2024 present in the industry space. The market intelligence was prepared to focus on the present trends, historical data evaluation, and financial research of the industry based on the complete market dynamics. By offering them a clear picture of this market, the report causes the user to reinforce the exhaustive capacity to design their key moves to extend their organizations. Deeply examined company profiles are presented on the basis of global market size, share, and revenue projection. The report calculates the current market performance by taking several key factors into accounts such as key drivers, opportunities, trends, and challenges.. The market size is given with market revenue, covering ...
Chinas huge and gradually aging population and strong biopharmaceutical sector have almost guaranteed a large but varied pharmaceutical market profile. Zhejiang, Guangdong, Shanghai, Jiangsu and Hebei provinces have always been among the top five most productive provinces in China. Each of these provinces has grown steadily by an average of 20 per cent per annum from 1998 to 2003 (with the exception of Jiangsu in 1998 and 1999) and reflects an increasingly healthy developing trend in the Chinese pharmaceutical industry. Most pharmaceutical firms are located in the southeastern zone that includes two well-developed areas and three under-developed areas. The two most popular areas of well-developed pharmaceutical industry, called the growth poles, are the Eastern China zone of which Zhejiang province is located in the centre and the South China zone represented by the Guangdong province. The total output value of these two provinces accounted for 21 per cent of the total output value of ...
Seven major pharmaceutical companies will conduct two studies, one to look at drug-related liver toxicity and the other aimed at a rare drug-related skin condition called Stevens-Johnson syndrome.
Cell Culture In Pharmaceutical Research - Read Online or Download Cell Culture In Pharmaceutical Research by Tamara Holloway Book For Free. Available forma: PDF, TXT , ePub , PDB , RTF, Audio Books
This winter was shaping up as a coming-out party for Vertex Pharmaceuticals Inc. After 2½ heady years of winning drug approvals and building an integrated research and commercial organization, it was ready to claim its status as one of the areas highest-profile biotechnology companies by occupying a marquee headquarters on the South Boston Waterfront. Vertexs move from 11 buildings scattered across Cambridge to its new $800 million two-building campus on Fan Pier will go on as scheduled, starting Dec. 17 and continuing through the early months of 2014. But its perch atop the Greater Boston life sciences hothouse suddenly looks far from secure. The company disclosed last week that a sharper-than-expected drop in sales of its lead drug was forcing it to shed 370 jobs, including 175 in its home state of Massachusetts.
Health Desk-Oct 12, 2017: Two pharmaceutical workers died and eight others fell sick overnight consuming apparently toxic molasses along with bread provided by the factory management in Rajshahi.. We were served last night the molasses along with bread as part of our daily meal . . . we fell sick soon after consuming the food, said one of the workers Team Pharma as he is being treated at Rajshahi Medical College Hospital (RMCH) along with nine of his co-workers.. Police said the workers were initially sent back to their home but they were rushed to the hospital with deteriorating condition and two of them died early this morning.. The factory is situated at BSCIC industrial estate in the city.. We are going to launch investigations to confirm as the cause behind the incidents, Godagari Police Stations officer in charge Hipzur Alam Munshi, told newsmen.. ...
Global Anemia Drugs Market Research Report 2016 Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.. In this Anemia Drugs market research report the core driving factors of this market were identified and the business partners & end users were elaborated. The structure of the business sector, patterns and challenges affecting the market globally are also a part of this extensive analysis. Various interviews and talks were conducted with the prominent leaders of this industry to obtain reliable and updated information pertaining to the market.. This market research report looks into and analyzes the Anemia Drugs market and illustrates a comprehensive evaluation of its evolution and its specifications. Another aspect that was considered is the cost analysis of the main products dominant in the global Anemia Drugs industry considering the profit margin of the manufacturers.. Get Sample Copy of this Report: https://goo.gl/5OEsy6. This Anemia Drugs industry market research ...
There is increasing evidence that a substantial proportion, probably the majority of drugs sold by big pharmaceutical companies based in developed countries were actually made by often poorly regulated firms based elsewhere, often China or India. To put it more directly, most so called pharmaceutical companies in the US and other developed countries have outsourced the actual manufacturing of drugs. Thus, most companies that appear to be pharmaceutical manufacturing companies are really just pharmaceutical marketing and development companies. (And not so much the latter, look here: Light DW, Lexchin JR. Pharmaceutical R&D; what do we get for all that money? Brit Med J 2012; 345: 22-25. Link here.) Pharmaceutical companies appear to be abandoning their core essence, but are content to market drugs under their logos without telling the patients who take them the real source of these products. This would appear to be a big scandal, but one that stays curiously anechoic ...
Added to this toxic mixture is the impact factor (IF). Just as many clinicians claim that contacts by pharmaceutical company representatives do not affect their prescribing behaviour, so editors are likely to deny that thoughts of a rising IF might influence their acceptance rates. In their paper published this week in PLoS Medicine, Andreas Lundh and colleagues analysed randomised controlled trials published in six high-impact general medical journals during two time periods a decade apart; they calculated the putative fall in IF that would have occurred had publication been denied to papers that were commercially sponsored [1].. Unsurprisingly, they found the expected association, since IF depends in turn on recent citation rates, and a body of literature shows that industry-sponsored trials attract more citations than those funded by a nonprofit source [2],[3]. There are reasons: for example, randomised controlled trials and meta-analyses are cited more frequently than clinical studies with ...
Colloidal Metal Particles Market: By Type, and Silica: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2026
Summary This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developmen
Read Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective, Clinical and Experimental Pharmacology and Physiology on DeepDyve, the largest online rental service for scholarly research with thousands of academic publications available at your fingertips.
Drug & Cosmetic Industry. February 1889: 34 Official website v t e. ...
"Shining stars: Luminaries in the generics industry". Drug Store News. July 16, 2019. "Newly Merged Amneal Pharmaceuticals to ... In 2007, the company acquired five divested drugs from Mylan which Mylan was forced to sell as part of their acquisition of the ... "How $6 billion generic drug company merger could affect this East Bay city and Roche". San Francisco Business Times. May 9, ... "How $6 billion generic drug company merger could affect this East Bay city and Roche". San Francisco Business Times. May 9, ...
"Medical Product Activities During the Federal Government Shutdown". For Industry. Food and Drug Administration. October 8, 2013 ... The FCC stopped work on its approvals of mergers in the telecommunications and broadcast television industries. The list of ... Approximately 45% of the Food and Drug Administration's 14,779 employees were furloughed. The FDA stopped routine food safety ... Drug Administration (FDA) Matters". The National Law Review. Archived from the original on October 21, 2013. Retrieved 2013-10- ...
"About the Project". Drug Industry Documents Archive. Retrieved 18 April 2013. Fugh-Berman, AJ (Sep 7, 2010). "The haunting of ... were initially made publicly available on the PLOS Medicine website but they are now available as part of the Drug Industry ... Godlee, F.; Groves, T. (2012). "The new BMJ policy on sharing data from drug and device trials". BMJ. 345: e7888. doi:10.1136/ ... "EMA workshop reveals divisions with industry . ecancer - News". Ecancer.org. 2012-12-20. Retrieved 2013-04-26. "Speaker ...
He was a grandson of William Davis Ticknor, founder of the publishing ... "William D. Ticknor". Drug and Cosmetic Industry. ...
Statisticians in the Pharmaceutical Industry; the Drug Information Association; the Royal Statistical Society; and the ...
CS1 maint: discouraged parameter (link) Kwon, Mee-yoo (28 April 2009). "Drug Scandal Jolts Showbiz Industry". The Korea Times. ... No stranger to controversy, Sung was caught for using the drug ecstasy in 2002, and previously published a book containing nude ...
"FDA approves Striverdi Respimat to treat chronic obstructive pulmonary disease". FDA News/Drug Industry Daily. 31 July 2014. ... To judge from the drug's mechanism of action and from experiences with related drugs, hypertension (high blood pressure), ... On 29 January 2013 the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) recommended ... FDA News/Drug Industry Daily. "New once-daily Striverdi (olodaterol) Respimat gains approval in first EU countries". Boehringer ...
Gina Kolata (November 9, 2003). "Ideas & Trends; The Drug Industry's Holy Grail". New York Times. director of medical research ...
Reporter for the Chain Drug Store Industry". Chain Drug Review. 15 May 2013. Archived from the original on 26 August 2014. ... Almus is a brand of generic prescription drugs sold in five countries. Almus is an umbrella brand for the wide range of lower ... "Chain to review drug charges as huge price gaps uncovered". Irish Independent. 9 July 2011. "Retail Week". October 2013. " ... "Alliance Boots: 'Good progress' with Walgreens - Retail News Breaks - Front Page - Chain Drug Review :: ...
"Patent Bill Splits the Drug Industry". The New York Times. August 15, 1982. p. NJ4. "Helms: From Reagan Ally to Foe in One ... After the Drug Enforcement Administration encountered opposition from Oliver North in investigating Noriega's role in drug ... The Helms bloc also failed to secure other limits to the program, including a motion to delete alcohol and drug residential ... Helms supported the tobacco industry, which contributed more than 6% of the state's GSP until the 1990s (the highest in the ...
Hall, M. Floyd (May 7, 1995). "Caregiver Drug Buy Raises Industry Issues". The Morning Call. ProQuest 392690616. Graham, ... In 1995 the company attracted media attention when one of its home care employees was arrested while buying illegal drugs, and ...
Hall, M. Floyd (7 May 1995). "Caregiver Drug Buy Raises Industry Issues". The Morning Call. ProQuest 392690616. George, John ( ... In 1995 the company drew negative attention when one of its home care employees was arrested while buying illegal drugs, and ... Griswold was among the corporations that pushed for better government oversight of the home care industry. Griswold hired Ray ...
Children and Drug Industry's Role". New York Times. Marilyn Elias (May 2, 2006). "New antipsychotic drugs carry risks for ... "Revealed: how drug firms 'hoodwink' medical journals , Society , The Observer". The Observer. "Prescription Drug Expenditures ... Drug companies routinely fund much of the research conducted by psychiatrists, advertise medication in psychiatric journals and ... The number of psychiatric drug prescriptions have been increasing at an extremely high rate since the 1950s and show no sign of ...
"FDA commissioner decries drug industry oligopoly". Supply Chain Dive. Vaillancourt, R (May 2012). "Drug shortages: what can ... Lazonick, William; Tulum, Öner (26 February 2019). "How High Drug Prices Inflate C.E.O.s' Pay". The New York Times. Tulum, Öner ... Drug companies on CEPI's scientific advisory panel, including Johnson & Johnson, Pfizer, and Japan's Takeda, pushed back. CEPI ... The financialization focus of the pharmaceutical industry, especially in the US, has been cited as an obstacle to innovation. ...
"China Orders Investigation into Drug Industry." BBC News. February 9, 2007. BBC News "200 remain hospitalized for food ... The drug quality inspectors at the factory that produced the Armillarisni A drugs failed to notice that the chemical diglycol ... The State Food and Drug Administration reported that their officials had resolved 14 cases involving fake drugs and 17 cases ... People's Daily News "China to Tighten Drug Safety Checks." China Daily. February 27, 2007. Xinhua "Death Toll Over Fake Drug ...
"Drug Industry Helping Obama Overhaul Health Care". FoxNews.com. 8 August 2009. Retrieved 30 May 2013. "In Negotiations, ...
953, 962 (1997)). Hemp Industries Ass'n v. Drug Enforcement Admin., 333 F.3d 1082 (9th Cir. 2003) In re Stepan Co., 660 F.3d ... individual industries, Federal, State, or local government agencies, or geographic regions," or (3) "significant adverse ...
Pollack, Andrew (20 April 2001). "Defensive Drug Industry: Fueling Clash Over Patents". The New York Times. Retrieved 27 ... She won several awards for her work on the effects of exposure to the drug diethylstilbestrol (DES) in the 1980s and 1990s, ... of the independent medicines journal La Revue Prescrire/Prescrire International and the International Society of Drug Bulletins ...
At the time, Novopharm was Canada's second largest drug manufacturer. Teva, a generic drug manufacturer based in Jerusalem, ... After its acquisition by pharmaceutical giant Teva Pharmaceutical Industries in 2000, it was renamed Teva Novopharm. The ... The company expanded to become Canada's second largest generic drug manufacturer and it also owned sites in the US and Hungary ... The acquisition made Teva the largest generic drug company in North America. Teva Canada maintains several facilities in the ...
Greene has studied the generic drug industry. His work appears in Slate. Prescribing by Numbers: Drugs and the Definition of ... Golden, Janet (October 7, 2014). "Generic drugs: An interview with Jeremy Greene". The Philadelphia Inquirer. Retrieved 6 April ...
"Obama Goes After A Different Drug Industry". The Huffington Post. Retrieved 2016-09-23. Official website American Addict at ... "Contrary to Press Headlines, Robin Williams Was on Drugs at the Time of His Death-Antidepressant Drugs". CCHR International. ... The central theme of the films revolves around prescription drug abuse in the United States. The franchise is being produced as ... Sheridan, Peter (2015-09-17). "The sad last days of Elvis - drugs, obesity and a live-in nurse". Retrieved 2016-09-23. "These ...
Ministry of Defence (United Kingdom) (18 February 2009). "Airborne troops strike at Taliban's drug industry". Directgov. ... The raid captured four drug factories and heroin and opium worth £50 million. In the early hours of February 7 the raid was ... Twenty Taliban fighters defending the drugs were killed. No UK personnel were killed in the assault. Correspondent, Thomas ... Coghlan, Tom (20 February 2009). "Commandos Target Drugs Labs Where Taleban And Mafias Reap $100M Profits". The Times. Harding ...
Problems in the Drug Industry, Part 16. Oral Contraceptives (Vol. 2), Hearings before the Subcommittee on Monopoly of the ... Problems in the Drug Industry, Part 16. Oral Contraceptives (Vol. 2), Hearings before the Subcommittee on Monopoly of the ... Having observed the extent to which the monetary interests of the drug companies and the voluntary health organizations were ...
"Winners by artist: Drag". Australian Record Industry Association. Archived from the original on 6 July 2011. Retrieved 29 ... These would go on to be the songs he sang for Drag. Middleton formed Drag with drummer and Powderfinger engineer Mark ... Drag released an EP, Gas Food Lodging, on 26 October 2003 through Dew Process. The band followed this up with several gigs in ... Drag reunited in 2005 to produce their debut studio album, The Way Out, which was released on 10 July 2005. In recording the ...
"Pharma industry feels the heat after drug scandal , Business". Dawn.Com. 3 February 2012. Archived from the original on 7 ... He was the first one to raise alarm about the possibility of a drug reaction, pointing to the common denominator of the ... "13 held in PIC drugs scandal". The Nation. Archived from the original on 18 November 2012. Retrieved 25 December 2012. ...
The drug industry accounted in 2006 for about 30 percent of the association's $62.5 million in financing, half through drug ... Carey, Benedict; Harris, Gardiner (July 12, 2008). "Psychiatric Group Faces Scrutiny Over Drug Industry Ties". The New York ... Senator Charles Grassley asked the APA to disclose how much of its annual budget came from drug industry funds. The APA said ... and she cites Thomas Bodenheimer and David Rothman who describe the extent of the drug industry's involvement with doctors. The ...
"Bankers Told How Science Aids Drug Industry's Growth". Chicago Daily Tribune. November 10, 1951. Retrieved 22 June 2015. ... Li, Jie Jack (2006). Laughing gas, viagra, and lipitor: the human stories behind the drugs we use. New York: Oxford University ... He was a pioneer in the field of anesthetic pharmacology, assisting in the development of two breakthrough drugs, Nembutal and ... Volwiler was a pioneer in the field of anesthetic pharmacology, assisting in the development of two breakthrough drugs, the ...
Psychiatric Group Faces Scrutiny Over Drug Industry Ties. New York Times Gantz, Sarah (8 January 2015). "Longtime Sheppard ... He has also expressed concern about conflict of interest that can occur between psychiatrists and drug companies. In 2015 ...
Common issues in drug development. Guidance for industry. (PDF), U.S. Department of Health and Human Services; Food and Drug ... Guidance for Industry and Food and Drug Administration Staff. ICH E5 (R1): Ethnic factors in the acceptability of foreign ... FDA Rare diseases: Common issues in drug development. Guidance for industry. see also the subgroup analysis section EMA/199678/ ... It also covers drug drug interaction studies. EMA/CHMP/483572/2012 Guideline on clinical investigation of medicinal products in ...
Houston Raceway is a motorsports complex featuring National Hot Rod Association (NHRA) races and a weekly drag racing program. ... In addition to the heavy industry in the business community, Baytown is home to the Cedar Crossing Industrial Park. With a ... The industries located along the ship channel and the bay are a major cause of the pollution.[25] ...
Extensive reform and overhaul in government regulation and inspection of the food and drug industry is needed in order to ... Nearly forty years later, in 1972, John G. Fuller published his expose of the food, drug and cosmetic industries, honoring ... 100,000,000 Guinea Pigs: Dangers in Everyday Foods, Drugs, and Cosmetics is a book written by Arthur Kallet and F.J. Schlink ... Jackson, J. "The Ergot Controversy: Prologue to the 1938 Food, Drug, and Cosmetic Act" J Hist Med Allied Sci 1968; XXIII: 248- ...
De Smet, Peter A.G.M. (December 1997). "The Role of Plant-Derived Drugs and Herbal Medicines in Healthcare". Drugs. 54 (6): 801 ... It needs gullibility for the industry to succeed. It doesn't make me popular with the public, but it's the truth.[123] ... 2006). "Drug-related hepatotoxicity". New England Journal of Medicine. 354 (7): 731-39. doi:10.1056/NEJMra052270. PMID 16481640 ... The U.S. Food and Drug Administration (FDA), has issued online warnings for consumers about medication health fraud.[157] This ...
... blaming a sudden drop in the price of raw materials for the pharmaceutical industry, which in turn lowered industry prices for ... The killer, Ricky Ray Malone, was allegedly in a drug-induced haze from methamphetamine use at the time he shot Green, and his ... "Local drug, supplement maker signs pact with Indian supplier Archived 2004-12-06 at the Wayback Machine.", Laurence Darmiento, ... Reddy's Laboratories, the third-largest drug company in India. Under the terms of the agreement, Dr. Reddy would provide ...
Food industry *meat industry in Canada. *meat industry in the U.S. ... COVID-19 drug development. *COVID-19 drug repurposing research. E. *Exposure to COVID-19 ...
... film was developed in the mid-1950s,[2][3] originally by DuPont,[2] Imperial Chemical Industries (ICI), and Hoechst. ... To bridge control surface gaps on sailplanes (gliders), reducing profile drag. ScienceEdit. *Amateur and professional visual ... found widespread use as a non-dimensional engineering drawing media in the aerospace industry due to its dimensional stability ...
The earliest Paleolithic stone tool industry, the Oldowan, began around 2.6 million years ago.[30] It contained tools such as ... It was completely replaced around 250,000 years ago by the more complex Acheulean industry, which was first conceived by Homo ... years ago and were replaced by more complex Middle Paleolithic tool kits such as the Mousterian and the Aterian industries.[32] ...
"Drug Trials Snapshots: Aklief". U.S. Food and Drug Administration (FDA). 11 October 2019. Archived from the original on 19 ... "Industry update: the latest developments in the field of therapeutic delivery, July 2018". Therapeutic Delivery (Review). 9 ... Aslam I, Fleischer A, Feldman S (March 2015). "Emerging drugs for the treatment of acne". Expert Opinion on Emerging Drugs. 20 ... Aslam I, Fleischer A, Feldman S (March 2015). "Emerging drugs for the treatment of acne". Expert Opinion on Emerging Drugs ( ...
JEL: L8 - Industry Studies: Services JEL: L80 - Geral. JEL: L81 - Retail and Wholesale Trade; Warehousing; e-Commerce. JEL: L82 ... JEL: L65 - Chemicals; Rubber; Drugs; Biotechnology. JEL: L66 - Food; Beverages; Cosmetics; Tobacco. JEL: L67 - Other Consumer ... JEL: L6 - Industry Studies: Manufacturing JEL: L60 - Geral. JEL: L61 - Metals and Metal Products; Cement; Glass; Ceramics. JEL ... JEL: L7 - Industry Studies: Primary Products and Construction JEL: L70 - Geral. JEL: L71 - Mining, Extraction, and Refining: ...
An alcoholic drink (or alcoholic beverage) is a drink that contains the recreational drug ethanol, a type of alcohol produced ... The global alcoholic drink industry exceeded $1 trillion in 2018.[1]. Alcohol is a depressant, which in low doses causes ... Alcohol is one of the most widely used recreational drugs in the world, with about 33% of people being current drinkers.[4] As ... In the alcoholic drinks industry, congeners are substances produced during fermentation. These substances include small amounts ...
In 2000, there were 14 industries authorized to produce generic drugs and about 200 registered generic drugs were being ... In 1998, the National Drug Policy was approved, whose purpose is to ensure safety, efficacy, and quality of drugs, as well as ... Brazil is among the greatest consumers markets for drugs, accounting for 3.5% share of the world market. To expand the access ... of the population to drugs, incentives have been offered for marketing generic products, which cost an average of 40% less than ...
Various health authorities, including Health Canada and the U.S. Food and Drug Administration (FDA), consider kōji-kin (A. ... When World War II brought rice shortages, the sake-brewing industry was dealt a hefty blow as the government clamped down on ... However, as the years went by, the government levied more and more taxes on the sake industry and slowly the number of ... in the Japanese food industry, the FDA and World Health Organization (WHO) also support the safety of A. oryzae for use in the ...
During his 2004 presidential campaign, Kucinich expressed support for a drug policy that "sets reasonable boundaries for ... He is a critic of the for-profit health insurance and pharmaceutical industries in the United States, and is concerned about ...
One year's worth of drugs normally costs about US$20,000 for a small child and over $50,000 for a teenager.[5] These drugs are ... Brody, Howard (2007). Hooked: ethics, the medical profession, and the pharmaceutical industry. Lanham, Md: Rowman & Littlefield ... Valenstein, Elliot S. (2002). Blaming the Brain : The Truth About Drugs and Mental Health. New York: Free Press. pp. 173-174. ... Parents and schools were not told that the charities were being paid by the drug companies to do this.[8][9] ...
... the tobacco industry launched "courtesy awareness" campaigns. Fearing reduced sales, the industry created a media and ... Drug Testing and Analysis. 11 (1): 140-156. doi:10.1002/dta.2471. hdl:10072/382912. PMID 30109771.. ... "Tobacco industry manipulation of the hospitality industry to maintain smoking in public places". Tobacco Control. 11 (2): 94- ... A tobacco industry-funded study conducted by the School of Technology of the University of Glamorgan in Wales, published in the ...
The Ohio State University is among the top 12 U.S. public research universities and 3rd among all universities in industry- ... and alcohol and other drug education.[53] ... 3rd among all American universities for private industry ...
Benedetti, Paul; MacPhail, Wayne (2002-01-01). Spin Doctors: The Chiropractic Industry Under Examination. Dundurn. p. 18. ISBN ... American chiropractors found that a slight majority favored allowing them to write prescriptions for over-the-counter drugs.[37 ...
Fielding falls for Daphne (Jerry), played by Jack Lemmon in drag; at the end of the film, Lemmon takes off his wig and reveals ... For his contributions to the film industry, Brown was inducted into the Hollywood Walk of Fame in 1960 with a motion pictures ...
In an interview with the Irish Independent Pat Hickey accused the show-jumping industry of dragging Irish sport "through the ... O'Connor won an individual showjumping gold medal with his horse Waterford Crystal but was later stripped of it because of drug ... "Showjumper Lynch withdraws after positive drug test". Irish Independent. 21 August 2008. Retrieved 22 August 2008.. ... cost team Germany a jumping gold after the horse ridden by Ludger Beerbaum was disqualified when it tested positive for drugs. ...
Radio Frequency Wireless Technology in Medical Devices - Guidance for Industry and Food and Drug Administration Staff. FDA ( ... U.S. Food and Drug Administration. Retrieved 2010-10-15.. *^ "Title 21-Food and drugs: Chapter i-Food and drug administration: ... U.S. Food and Drug Administration. Retrieved 2010-10-15.. *^ a b c d e f "General and Special Controls". Medical Devices. U.S. ... United States (Food and Drug Administration)Edit. Section 201(h) of the Federal Food Drug & Cosmetic (FD&C) Act[6] defines a ...
A year after leaving his own company under controversy, Simpson returned to the motorsports safety industry after his one-year ... colliding with Schrader and dragging his car up the track. Earnhardt collided head-on into the retaining wall at a critical ...
... a drug user, possibly a drug seller, and married to an angry, ungrateful black woman.[30] Obama was accused of dog-whistling to ... giving corporations more regulatory control over industry and financial markets, union busting, cutting pensions for future ...
Many social problems associated with poverty from crime to drug addiction have been prevalent in the area for decades. Despite ... and the massive strike of shirtwaist workers in New York's garment industry in 1909 ...
"Transfer Of Islamic Technology To The West, Part III: Technology Transfer in the Chemical Industries". History of Science and ... A. Al Dayela and N. al-Zuhair (2006), "Single drug therapy in the treatment of male sexual/erectile dysfunction in Islamic ... The Beginning of the Paper Industry, Foundation for Science Technology and Civilisation. ... Laura Shannon (2006). 1001 Inventions At Museum Of Science And Industry Manchester. ...
In Bangladesh, child prostitutes are known to take the drug Oradexon, an over-the-counter steroid, usually used by farmers to ... The supply and demand for children in the sex trade industry is greatly influenced by the structure of a country. Kevin Bales ... "Global Report on Trafficking in Persons 2012." United Nations Office on Drugs and Crime. N.p., n.d. Web. 8 Oct. 2013. ... "Global Report on Trafficking in Persons 2012." United Nations Office on Drugs and Crime. N.p., n.d. Web. 8 Oct. 2013. ...
... former mining towns mostly in the north of England where drug abuse had become commonplace since the decline of that industry ... Drugs - facing facts. The report issued by the RSA Commission on Illegal Drugs, Communities and Public Policy. The Royal ... War on drugs. References[edit]. *^ "Deaths England and Wales 1984-2006". Findmypast.com. Retrieved 27 August 2017.. .mw-parser- ... a b c Carey, Jim (March 1997). Recreational Drug Wars: Alcohol Versus Ecstasy - referenced from the book Ecstasy Reconsidered, ...
People would tie a rope around the necks and drag them over to a ditch."[249] Corpses were stacked along the streets of ... Nearly the full output of India's cloth, wool, leather and silk industries were sold to the military.[87] In the system that ... The bodies were picked over by vultures and dragged away by jackals. Sometimes this happened while the victim was still living. ... In the case of the textiles industries that supplied cloth for the uniforms of the British military, for example, they charged ...
Tablets or capsules of activated carbon are used in many countries as an over-the-counter drug to treat diarrhea, indigestion, ... The most commonly encountered form of chemisorption in industry, occurs when a solid catalyst interacts with a gaseous ... the so-called GAC rule encountered strong opposition across the country from the water supply industry, including the largest ... some alternatives to thermal regeneration systems have been employed in industry. Current alternative regeneration methods are ...
Rates of abuse can vary by occupation, with high rates in the construction and transportation industries as well as among ...
The size and rapid growth of the industry has led to complex and continuing debates with the whaling industry about the best ... he was told by the Great Spirit where to find special mushrooms that would give him the strength to drag the whale back to the ... Commercial whaling was historically important as an industry well throughout the 17th, 18th and 19th centuries. Whaling was at ... the whaling industry, with the moratorium in place, generates US$31 million (UK£20 million) per year.[96] ...
... she shouldnt have to worry that the drug was selected because of a pharmaceutical companys marketing skills. Thats why ... The drug industry says such bans, which also have been enacted in the last two years by Yale University and the University of ... The drug industry doles out $21 billion a year in marketing (90% directed at physicians), far more than it spends on consumer ... Stanfords decision also is further proof that voluntary drug industry guidelines arent working, as if that is a surprise. ...
The Drug Industry Documents Archive (DIDA) is a digital archive of pharmaceutical industry documents created and maintained by ... Wyeth paid medical ghostwriters to author journal articles about the drug. "About the Project". Drug Industry Document Archive ... The UCSF_Library created this digital archive in an attempt to facilitate further research into the drug industrys practice of ... DIDA is a part of the larger UCSF Industry Documents Library which includes the Truth Tobacco Industry Documents. The archive ...
The real problem is that we in the drug industry havent been discovering enough useful new drugs. As someone who works in the ... Those of us in the drug industry dont really know what to expect from the Obama administration (although were pretty sure ... All of those issues affect drug prices, but you have to have something to sell before you can talk about its price. ... For another thing, weve learned a lot more about potential problems with drug candidates, but not so much about how to fix ...
Experts say more drugs are being used to treat opioid addiction and the side effects of those anti-addiction medications in ... Secondary Drug Industry Booming Amid Opioid Epidemic. Written by Jessica Wakeman - Updated on July 17, 2017 ... In other words, the problem is not the drugs themselves, but the profit-making industries behind them, she said. ... A "drug cascade". A "drug cascade" refers to when doctors prescribe pills to treat something and then write a second ...
PHARMACEUTICAL company executives are watching nervously as drug prices come under growing criticism in Congress and states ... Business and Health; Drug Industry Nervous on Prices. By Milt Freudenheim Published: May 22, 1990. ... Most big drug companies oppose giving Medicaid discounts to the states, which spend $3.5 billion on drugs in Medicaid programs ... Makers of such drugs would have to bid against each other. Different drugs have different properties and different side ...
200-billion-a-year industry and the 176-nation World Customs Organization (WCO) will sign a declaration later this month to ... PARIS (Reuters) - Counterfeit drugs have become a $200-billion-a-year industry and the 176-nation World Customs Organization ( ... "We have more fakes than real drugs in the market," said Christophe Zimmermann, the WCOs anti-counterfeiting and piracy ... The World Trade Organization says fake anti-malaria drugs kill 100,000 Africans a year and the black market deprives ...
I simply would like a list of the drugs which have ,been researched, developed and marketed by a non-industry system. Well, ... Unethical practices - drug industry. Bret Jwood Jill Wood jwood at teleport.com Fri Sep 1 10:05:03 EST 1995 *Previous message: ... most ethical industries list. When the profit is high enough, I imagine the drug companies would do just about anything they ... Also, how about considering the medication Procardia..... It was on the list of the top 10 drugs in the US on sci.med, and it ...
The Wall Street Journal recently reported a story about Xigris, Eli Lillys new antisepsis drug. Sepsis, an infection of the ... How the drug industry is branding itself with bioethics.. By Carl Elliott ... The drug industry has even managed to turn peer-reviewed scientific literature into a sophisticated marketing device. It has ... Often, when a drug company is launching a new drug, it recruits a third party known as a Key Opinion Leader: an influential ...
Once the deal closes, Amazon could start selling prescription drugs directly through its site and delivering them via mail, ... Amazons playbook for upending healthcare just got a lot clearer - heres why it should terrify the pharmaceutical industry. ... Wholesalers, which are in charge of shipping drugs to pharmacies and hospitals, have been feeling the effects of Amazons ... Once the deal closes, Amazon could start selling prescription drugs directly through its site, delivering them via mail and ...
Food and Drug Industry The Economy, Industry and Development Issues ... The Economy, Industry and Development Issues Current news and events with regards to the economy, industry and urban ... SkyscraperCity , Asian Forums , Philippine Forums , Around the Philippines , The Economy, Industry and Development Issues ...
The Canadian government announced final regulations on Friday that should cut billions of dollars from patented drug prices ... The government said many countries with lower prices have more pharmaceutical industry investment and access to drugs that ... University of British Columbia professor Steve Morgan, who studies access to drugs and has advocated for a new national drug ... "The industry does take a lot of risk on in creating these products. It does cost money," said Pamela Fralick, president of ...
Wuergler says generic drug manufacturers do not operate at the same profit margins as well-known brands. "They tell me that the ... James says the nature of the industry means that a risk-based approach has to be taken. Sometimes a new partnership link is ... "I think regulation is an issue, but, unlike the retail sector, where the Payment Card Industry Data Security Standard has given ... And in the manufacturing area they are clearly aware that a malicious attack that produces bad drugs would be disastrous for ...
The plaintiff, Hemp Industries Association (HIA) claimed that CBD is not regulated by the Controlled Substances Act; the Drug ... Hemp Industries Association v. Drug Enforcement Administration, often shortened to HIA v. DEA, refers to two lawsuits ... "DEA seeks dismissal of hemp industry lawsuit fighting drug code for "marihuana extracts"". Hoban Law Group. 2017-01-13. ... Establishment of a New Drug Code for Marihuana Extract - A Rule by the Drug Enforcement Administration on 12/14/2016, Federal ...
... Share this:. *Click to share on Facebook (Opens in new window) ... after his company raised the price of the anti-infection drug Daraprim by more than 5,000 percent. The drug, which Turing ... "We need to get to the bottom of why were seeing huge spikes in drug prices that seemingly have no relationship to research and ... The lawmakers question Retrophin about its decision to raise the price of a kidney drug, Thiola, from $1.50 per tablet to $30 ...
It is a high molecular weight heparin drug ranging from 3,000 Da to 30,000 Da. The unfractionated... ... Unfractionated heparin drug is an anticoagulant drug. It is a high molecular weight heparin drug ranging from 3,000 Da to ... Unfractionated Heparin Drug Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025. Press ... The unfractionated heparin drug is a heterogeneous mixture of linear polysaccharide chains with variable biological activity ...
Kennedy: Medicinal marijuana is a Trojan horse for the recreational drug industry. ... In Rhode Island, where the district he represented in Congress is located, drug overdoses are a public health crisis. The ... Kennedy argues that lack of regulation in the pharmaceutical and alcohol industries is a prime example of why marijuana could ... making the drug seem more normalized and acceptable in society, though it still has dangerous impacts on minors. "The public ...
... ... PBMs are middlemen between drug makers and consumers when it comes to purchasing drugs and providing prescription coverage. The ... PBMs are middlemen between drug makers and consumers when it comes to purchasing drugs and providing prescription coverage. The ... Avista healthcare industry executive Charles Harwood said United BioSource has contributed unique capabilities and insights to ...
Study finds tobacco companies in 1980s and 1990s put pressure on drug companies to limit their marketing of nicotine gum and ... The drug companies then toned down their marketing strategies, the study says, focusing on smokers who had already decided to ... Tobacco companies in the 1980s and 1990s put pressure on drug companies to limit their marketing of nicotine gum and skin ... While the study focused on Philip Morris, other tobacco companies were also involved in pressuring the drug companies, Dr. Bero ...
Nasal Drug Delivery Technology market worldwide is projected to grow by US$25.4 Billion , driven by a compounded growth of 6.2 ... Global Nasal Drug Delivery Technology Industry. Tuesday, December 10, 2019 Drug News ... Nasal Drug Delivery Technology Market Review in China in US$ Million by End-Use: 2009-2017 Table 78: Chinese Nasal Drug ... Nasal Drug Delivery Technology Market Review in Italy in US$ Million by End-Use: 2009-2017 Table 129: Italian Nasal Drug ...
The Latest Reports with Statistics & Trends from Top Industry Sources. ... Understand the Allergy Drug Industry Quickly & Get Actionable Data Easily. ... Allergy Drugs Industry Forecasts - China Focus March 2018 $ 1800 The 2019-2024 World Outlook for Allergy Drugs January 2018 $ ... Allergy Rhinitis Drugs Sector: Worldwide Forecast until 2021 May 2017 $ 2500 Allergy Drugs Companies in China March 2018 $ 1800 ...
Report: Drug stocks prey for insiders as industry resists change Updated: December 21, 2012 - 9:18 AM EST * ... "The industry isnt capable or willing to regulate itself," Singer was quoted as saying. ... regulators for insider trading gained their edge as a result of secret information about drugs, devices and the companies that ...
Pharmaceutical Industry, Drug Quality and Regulation: Evidence from US and Italy. Vincenzo Atella, Jay Bhattacharya, Lorenzo ... Published: Pharmaceutical industry, drug quality and regulation.Evidence from US and Italy Journal Article Authors Vincenzo ... This paper examines the relationship between drug price and drug quality and how it varies across two of the most common ... Second, an MES+PC mix reduces the difference in price between the highest and lowest quality drugs on the market. The empirical ...
Drug Industry, Nonprofits Join Forces To Fight Worlds Neglected Diseases. by Sam Savage ... Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected ... particularly the wide gap between drug need and availability. But challenges remain, including who will pay for the drugs and ... Even though drug companies can expect to profit little from these ventures, a growing number see it as good business and are ...
... of people in the developing world are hanging in the balance ahead of a ruling that will determine whether Indias drug ... Indias Supreme Court to Rule on Generic Drug Industry. The lives of millions of people in the developing world are hanging in ... With no costs for developing new drugs or conducting expensive trials, Indias $26 billion generics industry is able to sell ... The case - involving Swiss drug maker Novartis AGs cancer drug Glivec - pits aid groups that argue India plays a vital role as ...
The drug industry goes beyond crony capitalism when it then charges Americans the highest drug prices in the world. ... The financial rip-offs arent the only problems with the out-of-control drug industry. Federal law requires all approved drugs ... the drug industry is required by law to fund a large portion of the FDAs drug review budget, which contributes to this weak ... variations on older drugs." Dr. Angell charges that the industry is "primarily a marketing machine to sell drugs of dubious ...
Marijuana legalization proponents and the cannabis industry have been holding their breath since Donald Trump took office, ... Cannabis industry braces for stronger drug enforcement under Trump. Activists, lawmakers react to Spicers comments ... There is still a federal law that we need to abide by in terms (of) … recreational marijuana and other drugs of that nature," ... "What weve seen in Colorado is that the longer our model exists, the smaller the illegal industry becomes. So if we are talking ...
"Pharmaceutical industry regulation undermines NICE drugs appraisal work ." Medical News Today. MediLexicon, Intl., 4 May. 2015 ... Publications, S. (2015, May 4). "Pharmaceutical industry regulation undermines NICE drugs appraisal work ." Medical News Today ... Visit our Pharma Industry / Biotech Industry category page for the latest news on this subject, or sign up to our newsletter to ... To illustrate how policy may support the pharmaceutical industry at the expense of the NHS, the authors give an example of how ...
... Share, Growth, Trends, and Forecast 2017 - 2025 - published on ... and other drugs can also hamper the anticonvulsants drug market. The anticonvulsants drug market has been segmented based on ... Anticonvulsants Drug Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025. 04-19-2017 01:34 ... You can edit or delete your press release Anticonvulsants Drug Market - Global Industry Analysis, Size, Share, Growth, Trends, ...
... http://www.reportlinker.com/p0197179/Global-Anemia-Drugs-in ... Drug and Medication Industry: Global Anemia Drugs industry More Market Research Report Check our Company Profile, SWOT and ... Pipeline Drugs II-4 List of Select Pipeline Drugs for Treatment of Anemia (2009) II-4 Patent Expiry for Major Anemia Drugs II-4 ... www.reportlinker.com/p0197179/Global-Anemia-Drugs-industry.html This report analyzes the worldwide markets for Anemia Drugs in ...
A Shifting Drug Industry Means New Opportunities in Translational Research. By Lisa Seachrist Chiu. Mar. 26, 2010 , 8:00 AM. ... In an effort to more efficiently develop drugs, the pharmaceutical industry is focusing on highly targeted, smaller clinical ... Choosing a career in industry may seem risky at a time when the pharmaceutical industry has shed many scientific jobs as a ... Despite the opportunities industry affords, its not for everyone. Scientists exploring industry careers "have to have the ...
  • However, Pfizer has obtained market exclusivity for the drug and its use in pain management through to 2018, and is therefore expected to maintain its leadership position. (openpr.com)
  • Huidian Research estimates that the sales scale of cardiovascular drugs in China in 2014 will reach about CNY 22 billion, and the figure will be CNY 45 billion by 2018. (pitchengine.com)
  • With over 850 in attendance during DATIA's 2018 Annual Conference, DATIA 2019 is expected to surpass over 900 industry professionals. (datia.org)
  • West is attending the Parenteral Drug Industry Congress on September 5-7, 2018! (westpharma.com)
  • In 2018 Hemp Industries Association alleged the DEA for created and was enforcing a similar regulation to the one that the ninth circuit court of appeals struck down in 2004. (wikipedia.org)
  • According to market analysts, the global ophthalmic drugs market will grow from USD 16 billion in 2012 to USD 21.6 billion in 2018, observing growth at an average CAGR of 5.2% during the next 4-5 years. (sbwire.com)
  • Researchmoz added Most up-to-date research on "Optic Nerve Disorders Drug Development Pipeline Review, 2018" to its huge collection of research reports. (webnewswire.com)
  • Viread- Drug Insights, 2017" highlights the Viread marketed details, pipeline status and the Global API Manufacturers along with the location. (medgadget.com)
  • Featuring 20+ sessions hosted by medical and technology industry leaders, networking events, the 2017 Quad Impact Challenge innovation battle and $10,000 cash reward presentation, and dozens of sponsor displays. (medgadget.com)
  • The FDA okayed 46 "novel" drugs - whose chemical structure hadn't been previously approved - in 2017, the most in at least 15 years. (propublica.org)
  • In 2017, the FDA's Center for Drug Evaluation and Research denied 19.7 percent of all applications for new drugs, biologics, and efficacy supplements, down from a 2010 peak of 59.2 percent, according to agency data. (propublica.org)
  • This new study focuses on industry trends and forecasts with historical data (2007, 2012 and 2017) and long-term forecasts through 2022 and 2027 are presented. (bharatbook.com)
  • The global anti-Parkinson's drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1% from 2017 to 2022. (bccresearch.com)
  • And Medicare uses that high-end list price to calculate how rapidly beneficiaries reach the dreaded doughnut hole, where patients pay a bigger share of the price of the drug after their spending hits $3,700, the 2017 benchmark. (fiercehealthcare.com)
  • The Global Onychomycosis (Tinea Unguium) Drug Market Research Report 2017 give insights upon the world's major regional market conditions of the Onychomycosis (Tinea Unguium) Drug industry which mainly focus upon the main regions which include continents like North America, Europe and Asia and the main countries i.e. (beforeitsnews.com)
  • According to the most recent data analyzed by The New York Times , an estimated 65,000 people died of drug overdoses in the United States in 2016, the majority of them from opioid overdose. (healthline.com)
  • The Global Hyperphosphatemia Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Hyperphosphatemia Drug industry. (mynewsdesk.com)
  • Pertaining to drug approvals, the total number of new drugs approved for marketing in the United States fluctuated between 2005 and 2016, ranging from 179 to 263 drug approvals annually. (gao.gov)
  • And since the FDA fast-tracked approval of Nuplazid and it went on the market in 2016 at a price of $24,000 a year, there have been 6,800 reports of adverse events for patients on the drug, including 887 deaths as of this past March 31. (propublica.org)
  • the Drug Enforcement Administration took steps in December, 2016 to index "marihuana extract" as a substance under its purview, with code number 7350. (wikipedia.org)
  • however, as PEG-rhGHbelongs to national new First-in-Class drugs, a phase IV clinical trial is a must, and mass production is expected to begin in 2016. (prweb.com)
  • This guidance incorporates the comments received for and finalizes the draft guidance for industry of the same name issued July 1, 2016. (federalregister.gov)
  • All submissions received must include the Docket No. FDA-2016-D-1662 for "Vulvovaginal Candidiasis: Developing Drugs for Treatment. (federalregister.gov)
  • The real concern is that Colorado provided $3 billion in economic impact from the legal cannabis industry in 2016, and 20,000 direct jobs," she said. (wkbw.com)
  • WASHINGTON, Nov. 30, 2016 - As he heads out the door, President Obama will put in place two key parts of his administration's strategy to restrict the use of antibiotics in agriculture, part of a broader strategy for fighting drug-resistant germs. (agri-pulse.com)
  • However, increasing use of anticoagulants in dialysis as an alternative has decreased the usage of unfractionated heparin, which is likely to restraint the growth of the market for unfractionated heparin drug during the forecast period. (mynewsdesk.com)
  • The drug discovery services market is projected to reach USD 21.4 billion by 2025 from USD 11.1 billion in 2020, at a CAGR of 14.0% during the forecast period. (prnewswire.com)
  • Of all these therapeutic segments, oncology will grow at the fastest CAGR in the drug discovery services market during the forecast period. (prnewswire.com)
  • The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their manufacturing and drug discovery R&D operations to the region. (prnewswire.com)
  • How will each of the drugs in the Parkinson's therapeutics market grow over the forecast period and how much revenue will these drugs account for in 2026? (prnewswire.co.uk)
  • Orbis Research: Statistical Analysis for "PharmaPoint: Ulcerative Colitis-Global Drug Forecast and Market Analysis to 2025" capacity, production, production value, cost/profit, supply/demand and import/export. (medgadget.com)
  • The major global barrier for the UC market will be the sales erosion of blockbuster biologic drugs for moderate to severe UC space due to launch and increasing use of anti-tumor necrosis factor (TNF) biosimilars over this forecast period. (medgadget.com)
  • The report also throws light upon the Productions, Supply, Sales, Demand, Market Status and Forecast of the Onychomycosis (Tinea Unguium) Drug industry in the North American markets. (beforeitsnews.com)
  • Reportlinker.com offers immediate download access to top market reports on the Allergy Drug Industry. (reportlinker.com)
  • Visit our Pharma Industry / Biotech Industry category page for the latest news on this subject, or sign up to our newsletter to receive the latest updates on Pharma Industry / Biotech Industry. (medicalnewstoday.com)
  • On Wednesday, things got worse for Shkreli as BIO, the biotech industry association, gave him the boot. (washingtonpost.com)
  • Research Driven Investing releases regular market updates on the Biotech Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. (yahoo.com)
  • NEW YORK, NY--(Marketwire - Nov 21, 2012) - The Biotech Industry has skyrocketed in 2012 as an increase in the number of new drug approvals has boosted investor optimism within the industry. (yahoo.com)
  • MarketReportsOnline.com adds "Prostate Cancer Treatment Drugs Industry Forecasts - China Focus " report to its research store. (pitchengine.com)
  • This study focuses on China's Prostate Cancer Treatment Drugs industry forecasts. (pitchengine.com)
  • This new study focuses on industry trends and forecasts with historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. (pitchengine.com)
  • We have published over 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. (pitchengine.com)
  • This Drug Injection Device Sales Industry report also takes into account the past price of and future price as per the supply-demand relation along with perspectives and Drug Injection Device Sales Industry forecasts. (beforeitsnews.com)
  • A thorough SWOT analysis & investment analysis is provided in the report which forecasts imminent opportunities for the Drug Injection Device Sales Industry market players. (beforeitsnews.com)
  • He says the need to shield research and development networks from interconnected manufacturing and production networks is another feature of the industry. (computerweekly.com)
  • We need to get to the bottom of why we're seeing huge spikes in drug prices that seemingly have no relationship to research and development costs," said McCaskill in a statement. (denverpost.com)
  • UBC president Patrick Lindsay said his "team of clinical and commercial experts understands the many facets of drug development, market access, and safety. (forbes.com)
  • The case - involving Swiss drug maker Novartis AG's cancer drug Glivec - pits aid groups that argue India plays a vital role as the pharmacy to the poor against drug companies that insist they need strong patents to make drug development profitable. (law.com)
  • The pharmaceutical industry spends far more on marketing and advertising to physicians and patients than what it spends on research and development. (counterpunch.org)
  • The Johns Hopkins-MedImmune Scholars Program , believed to be a first-of-its-kind training program between a major university and a biopharmaceutical company in the United States, enables students to learn firsthand the process and challenges of drug discovery and development while still earning a traditional Ph.D. Research projects, managed by mentors at Johns Hopkins and MedImmune, may be conducted at both locations. (hopkinsmedicine.org)
  • That's not surprising when you consider the crucial role for-profit industry has always played in the development and deployment of basic scientific discoveries. (sciencemag.org)
  • Choosing a career in industry may seem risky at a time when the pharmaceutical industry has shed many scientific jobs as a result of the global recession and looming restructuring of the drug-development process. (sciencemag.org)
  • The move to industry has allowed him to "bring therapies to millions of people who weren't able to be helped," says Saltarelli, now divisional vice president for neuroscience development at Abbott Laboratories. (sciencemag.org)
  • The Hyperphosphatemia Drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions development status. (mynewsdesk.com)
  • Whats more, the Hyperphosphatemia Drug industry development trends and marketing channels are analyzed. (mynewsdesk.com)
  • However, the high cost of drug discovery and development and stringent regulations governing drug discovery and animal usage in testing may restrict the growth of this market to a certain extent. (prnewswire.com)
  • As a result, the Asia Pacific region has become a major destination for drug discovery and development. (prnewswire.com)
  • At the time, PhRMA President John Castellani argued that the debate over drug pricing has gone "askew" and that research at development for such drugs comes at a high cost to companies. (washingtonpost.com)
  • What Parkinson's disease drugs are in the development pipeline? (prnewswire.co.uk)
  • Evaluate the marketing status and exclusivity details of Viread to exploit opportunities for generic drug development opportunities. (medgadget.com)
  • Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. (pitchengine.com)
  • Drug industry spending for research and development increased from $82 billion in 2008 to $89 billion in 2014. (gao.gov)
  • In addition, experts noted that market pressures such as rising research and development (R&D) costs, fewer drugs in development, and competition from generic drugs, have driven structural changes in the industry such as increased use of acquisition by large drug companies to obtain access to new research. (gao.gov)
  • From 2008 through 2014, worldwide company-reported R&D spending, most of which went to drug development (rather than research), increased slightly from $82 billion to $89 billion in 2015 dollars. (gao.gov)
  • Not to bash Big Pharma - there needs to be, I suspect, a few larger entities which can manage risk across portfolios, and deliver economies of scale in repeatable processes like drug development and manufacture. (sciencemag.org)
  • Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. (yahoo.com)
  • The Schizophrenia Drug market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. (cyberessays.com)
  • A session on the evolution of the community pharmacist to specialty pharmacist sought to help attendees learn the educational requirements necessary to best serve specialty patients and other important information and included Community Specialty Pharmacy Network VP industry relations Nick Calla, National Association of Specialty Pharmacy founder and CEO Gary Cohen and URAC senior manager for product development Terri Smith Moore. (drugstorenews.com)
  • We present a number of theoretical considerations and several case examples to demonstrate complexities in applying (1) the proposed transporter decision trees and associated criteria for studying a broad spectrum of transporters to derive actionable information and (2) the recommended model-based approaches at an early stage of drug development to prospectively predict DDIs involving time-dependent inhibition and mixed inhibition/induction of drug metabolizing enzymes. (nih.gov)
  • The purpose of this guidance is to assist sponsors in the overall clinical development program and clinical trial designs to support drugs for treating vulvovaginal candidiasis (VVC). (federalregister.gov)
  • Will the drugs under development fulfil the unmet needs of the UC market? (medgadget.com)
  • The key market opportunities lie in addressing unmet needs through the development of oral agents with superior efficacy and safety profile, low cost, curative UC therapy as well as drugs that help minimise colorectal cancer risk. (medgadget.com)
  • The decision won't affect Pfizer all that much, but it could signal a major issue for the drug development industry in general. (fool.com)
  • Dividends can help investors ride the waves of slow drug development times. (fool.com)
  • The rising initiatives from government for improvement of healthcare facilities, especially in the developing economies such as China and India and the technical development in drug delivery techniques are also some reasons that are driving the global ophthalmic drugs market. (sbwire.com)
  • This article discusses how we urgently need surrogate endpoints to enhance the speed of assessment in the development of drugs in this presently under-researched area and the potential benefits they can bring such as lowering costs, reducing time to NDA, bypassing need for phase II studies and reviving dead drugs. (ddw-online.com)
  • This is a radical departure from cytotoxic drug development. (ddw-online.com)
  • The diverse nature of these highly specialised techniques will by necessity concentrate the early phase of drug development in a few centres of excellence rather than the current more diffuse pattern. (ddw-online.com)
  • Creating innovative partnerships between an increasingly consolidated and globalised industry and major cancer treatment centres is now essential to enhance the speed of drug development. (ddw-online.com)
  • Cancer drug development is entering a remarkable new phase. (ddw-online.com)
  • Not only are the delivery of proteins, peptides, insulin and vaccines being revolutionized by new drug delivery technologies, but novel therapeutic approaches, such as RNAi and targeted cancer therapies are being shaped by new drug delivery systems in development. (prweb.com)
  • We hope it will improve the productivity and effectiveness not only for those who develop drugs but for those who regulate drug development," he said. (bio-medicine.org)
  • This will help in the development of drugs both in avoiding these side effects in the future and maybe developing tests to help identify people at high risk," she said. (bio-medicine.org)
  • As a result, hundreds of new rare-disease treatments have entered the market over the past few decades, and orphan drug development has become a highly profitable industry. (the-scientist.com)
  • Some economists and scientists suggest that companies have abused the financial incentives for rare-disease drug development, and they predict a coming backlash to the hefty price tags of these medications. (the-scientist.com)
  • For one, some studies suggest that the cost of drug development has increased across the board-one analysis by researchers at the Tufts Center for the Study of Drug Development estimated that the average research and development (R&D) costs per drug went up from $802 million for products approved in the 1990s to $2.6 billion for those approved between 2005 and 2013. (the-scientist.com)
  • Although over 50 small-molecule drugs have entered clinical development, only two compounds have received a licence: maraviroc, which targets CCR5 for the treatment of HIV infection, and plerixafor, which targets CXCR4 to treat lymphoma and multiple myeloma. (diamond.ac.uk)
  • Included is an understanding of the strategy deployed for pricing drugs and new technologies as well as the market sizing exercise to identify where future research and development investments should be made. (coursera.org)
  • Helped me in gaining a better understanding of the various processes involved in the development of a drug and medical device. (coursera.org)
  • the drug development challenges within the pharmaceutical industry. (coursera.org)
  • we talked about the challenges that one faces in drug development. (coursera.org)
  • In addition, the report brings the key players and their product development as well as the latest trend that should prove out to be quite beneficial for the new entrants to understand the industry in a better way. (beforeitsnews.com)
  • Avista healthcare industry executive Charles Harwood said United BioSource 'has contributed unique capabilities and insights to the biopharmaceuticals industry, which have enabled countless pharmaceutical companies to accelerate approvals of their therapies, expand access to patients in need, and help ensure medications are safe to use. (forbes.com)
  • Get Industry Insights. (reportlinker.com)
  • Orbis Research Present's Viread -Drug Insights, 2017And has been prepared based on an in-depth market analysis with inputs from industry experts. (medgadget.com)
  • Pharmaguy curates and provides insights into selected drug industry news and issues. (scoop.it)
  • In terms of distribution channel, the global benzodiazepine drugs market has been split into hospital pharmacies, retail pharmacies and others.Each of the segments has been analyzed in detail for market trends, recent trends and developments, drivers, restraints, opportunities and useful insights. (prnewswire.com)
  • In terms of region, the anticonvulsants drug market has been classified into Asia Pacific, Europe, Middle East & Africa, North America, and Latin America. (openpr.com)
  • North America , which includes the US and Canada , accounted for the largest share of the drug discovery services market. (prnewswire.com)
  • In terms of region, the drug rescue market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. (openpr.com)
  • North America is projected to account for the major share of the drug rescue market owing to increasing incidence of severe and chronic medical conditions. (openpr.com)
  • In terms of geography, the global alcohol breathalyzer and drug testing equipment market is segmented into North America, the MEA, Asia Pacific, Europe, and Latin America. (sbwire.com)
  • The US, as well as the overall region of North America, represents the largest market for the ophthalmic drugs industry. (sbwire.com)
  • Derek Lowe's commentary on drug discovery and the pharma industry. (sciencemag.org)
  • It was definitely a wake-up call seeing how science can be done in so many different ways, and how MedImmune has so many resources to make science more fun and easy to do," says Majewska, who has career aspirations in the biopharmaceutical industry. (hopkinsmedicine.org)
  • The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing demand for outsourcing analytical testing and clinical trial services, initiatives for research on rare diseases and orphan drugs, and focus on drug discovery. (prnewswire.com)
  • These accomplishments could not have been achieved without the innovations of the biopharmaceutical industry and the dedication and skill of FDA's drug review staff. (yahoo.com)
  • Three of the largest pharmaceutical companies - Merck, Bristol-Myers Squibb, and Burroughs-Wellcome - have broken with the industry's longstanding policy of refusing to offer discounts on Medicaid drugs. (nytimes.com)
  • Most big drug companies oppose giving Medicaid discounts to the states, which spend $3.5 billion on drugs in Medicaid programs. (nytimes.com)
  • The executive committee of the board of the Pharmaceutical Manufacturers Association, a trade group, met on May 3 and formally rejected ''proposals to tie the availability of prescription drugs to the willingness or ability of companies to grant discounts or rebates. (nytimes.com)
  • The whole issue of pricing is a very serious one for the companies and their stock price-earnings ratios,'' said Hemant K. Shah, an independent pharmaceutical analyst in Warren, N.J. ''Drug unit sales are declining and about 70 percent of sales growth is coming from price increases. (nytimes.com)
  • Indeed, he added, one advantage for investors of having drug stocks had been that the companies could always raise the prices of their products, even in a recession. (nytimes.com)
  • Jim Parks, who heads the $570 million Medi-Cal Drug Discount Program in California, said that ''a couple of companies are showing interest'' in discussing discounts. (nytimes.com)
  • When the profit is high enough, I imagine the drug companies would do just about anything they felt they could get away with in order to maintain their cash-flow. (bio.net)
  • To answer that question, we need to ask another one: Why do drug companies want to give money to bioethicists in the first place? (slate.com)
  • While KOLs are frequently offered positions as consultants or advisers, the drug companies do not expect them to push their products directly. (slate.com)
  • Some public relations agencies advise drug companies to encourage their KOLs to work for many different companies in order to maintain a posture of objectivity. (slate.com)
  • TORONTO (Reuters) - The Canadian government announced final regulations on Friday that should cut billions of dollars from patented drug prices that are among the highest in the world, overcoming heavy opposition from pharmaceutical companies who may eventually challenge the new rules in court. (reuters.com)
  • In the past, drug companies have gone as far as the Supreme Court of Canada to challenge PMPRB guidelines. (reuters.com)
  • WASHINGTON - A Senate committee has launched an investigation into exorbitant drug price hikes by Turing Pharmaceuticals and three other companies, responding to public anxiety over rising prices for critical medicines. (denverpost.com)
  • Tobacco companies in the 1980's and 1990's put pressure on drug companies to limit their marketing of nicotine gum and skin patches that help people quit smoking, according to a new study of tobacco industry documents. (nytimes.com)
  • The drug companies then toned down their marketing strategies, the study says, focusing on smokers who had already decided to quit rather than making broader appeals based on the health benefits of quitting. (nytimes.com)
  • While the study focused on Philip Morris, other tobacco companies were also involved in pressuring the drug companies, Dr. Bero said. (nytimes.com)
  • The story said that since 2007, 97 people charged or sued by U.S. regulators for insider trading gained their edge as a result of secret information about drugs, devices and the companies that make them, according to data compiled by Bloomberg. (philly.com)
  • Drug companies and nonprofit organizations are joining forces to develop new drugs and vaccines to target so-called "neglected" diseases that claim millions of lives in the developing world each year. (redorbit.com)
  • C&EN Senior Editor Lisa Jarvis explains that just a decade ago major pharmaceutical companies had largely abandoned developing treatments for these neglected diseases. (redorbit.com)
  • The article describes how public-private partnerships between drug companies, nonprofits, and philanthropists are springing up to address this problem, particularly the wide gap between drug need and availability. (redorbit.com)
  • Even though drug companies can expect to profit little from these ventures, a growing number see it as good business and are excited about a steady stream of new drug candidates, the article notes. (redorbit.com)
  • The lives of millions of people in the developing world are hanging in the balance ahead of a ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines. (law.com)
  • From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether India's drug companies can continue to provide cheap versions of many life-saving medicines. (law.com)
  • With no costs for developing new drugs or conducting expensive trials, India's $26 billion generics industry is able to sell medicine for as little as one-tenth the price of the companies that developed them, making India the second-largest source of medicines distributed by UNICEF in its global programs. (law.com)
  • Indian pharmaceutical companies such as Cipla, Cadila Laboratories and Lupin have emerged over the past decade as major sources of generic cancer, malaria, tuberculosis and AIDS drugs for poor countries that can't afford to pay Western prices. (law.com)
  • But Western companies argued that India's generic manufacturers were cutting the incentive for major drug makers to invest in research and innovation if they were not going to be able to reap the exclusive profits that patents bring. (law.com)
  • International drug companies have accused India of disregarding intellectual property rights, and have pushed for stronger patent protection that would weaken India's generics industry. (law.com)
  • Public health activists say the question goes beyond Glivec to whether drug companies should get special protection for minor tweaks to medicines that others could easily have uncovered. (law.com)
  • t is remarkable what very profitable drug companies-as they merge into fewer giant multinationals-continue to get away with by way of crony capitalism. (counterpunch.org)
  • Some companies reaped billions of dollars in revenues when they were granted exclusive rights to market a drug, such as Taxol, developed by the government's National Institutes of Health (NIH). (counterpunch.org)
  • He said that drug companies, while not colluding, 'have all looked at each other and said, 'None of us needs to compete on price if we just hold the line. (counterpunch.org)
  • Over the years, the government has fined drug companies billions of dollars for pushing unapproved uses of drugs. (counterpunch.org)
  • In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. (mynewsdesk.com)
  • rising R&D expenditure by pharmaceutical & biopharmaceutical companies and the availability of latest techniques, instruments, and facilities for drug discovery research are driving the growth of this region. (prnewswire.com)
  • Hours after he insisted on national television that the $750-a-pill price on the formerly $18-a-pill drug was the right one for business reasons, he announced that he would lower the price - a move that galvanized critics and set a precedent for other companies to do the same. (washingtonpost.com)
  • We serve all sizes and types of companies spanning across various industries. (pitchengine.com)
  • And they will be there to see and learn firsthand about product and service offerings showcased by companies like yours that can enhance and increase the success of their drug free workplace programs. (datia.org)
  • Oxfam estimates the four drug companies avoided paying an estimated €3.16 billion in taxes in nine advanced economies and €95 million in six developing countries. (euractiv.com)
  • According to the report " Prescription for Poverty ", the drug companies appear to underpay an estimated €1.2 billion in taxes in six European countries (Denmark, France, Germany, Italy, Spain and the UK) over a three year period. (euractiv.com)
  • Drug companies appear to be cheating governments out of tax revenues that could be invested in healthcare. (euractiv.com)
  • Companies like those mentioned in the report follow accounting procedures and tax laws in the countries they operate in, paying taxes accordingly," a source from the European Federation of Pharmaceutical Industries and Associations (EFPIA) told EURACTIV. (euractiv.com)
  • DIDA contains: internal pharmaceutical company documents correspondence between drug companies and physicians, researchers and educational institutions regulatory and legal documents court filings depositions expert reports internal University documents Documents come from a variety of sources including: Lawsuits against Merck & Co. regarding the marketing and use of Vioxx The landmark whistleblower case involving Neurontin (gabapentin) and off-label marketing: United States of America ex rel. (wikipedia.org)
  • Additionally, 67% of drug companies increased their annual profit margins during the same period-with margins up to 20 percent for some companies in certain years. (gao.gov)
  • About 67 percent of all drug companies saw an increase in their annual average profit margins from 2006 to 2015. (gao.gov)
  • For comparison, the annual average profit margin across non-drug companies among the largest 500 globally fluctuated between 4 and 9 percent. (gao.gov)
  • The largest 10 companies had about 38 percent of the drug industry's sales revenue in 2014. (gao.gov)
  • In addition to grants, several federal tax provisions provided incentives for industry R&D spending, including the orphan drug credit, available for companies developing drugs intended to treat rare diseases, which increased more than five-fold from 2005 through 2014. (gao.gov)
  • As pharma companies underwrite three-fourths of the FDA's budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits. (propublica.org)
  • In return for accelerated approval, drug companies commit to researching how well their drugs work after going on the market. (propublica.org)
  • The share of total clinical (industry-sponsored) clinical trials and the share of total clinical trial enrollment held by the top 10 companies has been declining pretty steadily over that time as well. (sciencemag.org)
  • The authors of this new paper identify several trends that have delayed the expected mega-consolidation of the industry - the move to rare diseases, the rise of monoclonal antibody therapies (done at first by a number of players outside the big 10 companies at the time), the greater availability of outsourced services, and - in recent years - the relatively easy access to capital. (sciencemag.org)
  • Around the world pharmaceutical companies have been polluting the environment for decades now, with the result that even drinking water supplies have become contaminated with measurable amounts of dangerous chemical drugs. (bibliotecapleyades.net)
  • A recent study ( Pharmaceutical Manufacturing Facility Discharges can substantially Increase the Pharmaceutical load to U.S. Wastewaters ) confirmed that water treatment plants taking discharges from pharmaceutical companies are putting high concentrations of drugs into American waterways. (bibliotecapleyades.net)
  • On average, each of these authors had dealings with 10.5 different drug companies. (ashp.org)
  • Six percent owned an equity stake in one or more drug companies. (ashp.org)
  • Although the survey s questions dealt with authors relationships with drug companies, the guideline topics were not restricted to drug therapy but also described diagnosis and other aspects of disease management. (ashp.org)
  • Fifty-nine percent of the 80 respondents who returned a follow-up survey acknowledged having a relationship with one or more companies whose drugs were considered in the guideline. (ashp.org)
  • Major drug manufacturers have looked to biotech companies to help offset major revenue losses from expiring patents as it is less time consuming than developing new drugs through R&D. (yahoo.com)
  • The report identifies the leading companies in the industry, and offers strategic analysis of the key factors influencing the market. (ibisworld.com)
  • HAWTHORNE , N.Y. An Israeli generic drug maker has sued three other companies, alleging patent infringement. (drugstorenews.com)
  • Major companies profiled in the drug delivery systems market include AstraZeneca plc. (bccresearch.com)
  • Also for the first time, the states are suing senior executives at two generic drug companies. (ctnewsjunkie.com)
  • The 15 drugs manufactured by 18 companies make everything from Doxycycline, which is a delayed release antibiotic, to Acetazolamide, which is used to treat glaucoma and epilepsy. (ctnewsjunkie.com)
  • Check out the Fool's new free report " Secure Your Future With 9 Rock-Solid Dividend Stocks ," where you'll find one drug developer and eight other promising companies. (fool.com)
  • Major ophthalmic companies from around the world are widening their focus on combination drugs - medications that involve the use of two or more medicines for retinal disorders. (sbwire.com)
  • THURSDAY, Sept. 27 (HealthDay News) -- Seven major pharmaceutical companies are banding together to develop genetic tests that predict which patients will have adverse side effects from drugs. (bio-medicine.org)
  • Whereas, on the basis of sales, data related to sales volume, sales price, cost, sales income, and profit margin etc. of Drug Injection Device Sales Industry used in different fields, sold in different regions and by different companies is provided in this report. (beforeitsnews.com)
  • And before the mid-1980s, when governments began passing legislation that encouraged companies to invest in these uncommon conditions, industry was reluctant to pour its money into products with such minuscule markets. (the-scientist.com)
  • If you look at it from an economic perspective, at the time there was a clear market failure-there was no incentive for companies to develop [an orphan] drug, it just didn't make sense," says Dyfrig Hughes, a health economist at Bangor University in the U.K. who is involved in clinical trials for rare conditions. (the-scientist.com)
  • Post-marketing studies are a major activity in the life cycle of a licensed drug/medicinal product and are regularly conducted by pharmaceutical companies and contract research organisations. (bmj.com)
  • According to the German Medicinal Products Act (Arzneimittelgesetz, AMG) all companies initiating a post-marketing study in the German drug market are required by law to register their study. (bmj.com)
  • Drugs) companies are beginning to shift research budgets towards more aggressive marketing of existing products. (healthy.net)
  • To encourage pharmaceutical companies to make more money (as if they've ever needed encouragement), the editors surmise that drug companies may be looking for the next blockbuster rather than developing a 'niche' drug. (healthy.net)
  • The FDA is expected to publish a series of notices in December formally approving the last of the drug companies' labeling changes, which are expected to be effective Jan. 1. (agri-pulse.com)
  • All companies agreed to end the sale of the drugs for growth promotion, and that effectively ends such usage, according to Michael Taylor, who stepped down earlier this year as FDA's deputy commissioner for foods. (agri-pulse.com)
  • After threats from Congress to crack down on industry swag, manufacturers agreed in 2002 to limit gifts to those of "modest value. (latimes.com)
  • Only 15 new drugs were approved by America's drugs agency, the Food and Drug Administration, during 2002 compared with an average during the previous five years of 31. (healthy.net)
  • Or why the University of Chicago's MacLean Center for Clinical Medical Ethics cosponsored a recent conference with Pfizer, Merck, and PhRMA, the pharmaceutical industry trade organization, on inequities in American health care. (slate.com)
  • Key players operating in the global unfractionated heparin drug market include Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, LEO Pharma A/S, Pfizer, Inc., and Sanofi S.A. (mynewsdesk.com)
  • Bextra, sold by Pfizer, Inc., another anti-inflammatory analgesic drug was approved by the FDA in 2001, and was then removed in 2005 because of concerns about increased risk of heart attacks and strokes, as well as serious, sometimes fatal skin reactions. (counterpunch.org)
  • Bruce Littman, president of Translational Medicine Associates, LLC, in Stonington, Connecticut, moved to an industry position at Pfizer after studying the pathogenesis of rheumatoid arthritis as a professor at Virginia Commonwealth University in Richmond. (sciencemag.org)
  • After a split vote by a Food and Drug Administration advisory panel, the agency will have the final say on whether Pfizer 's (NYSE: PFE) tafamidis meglumine is approved in the U.S. (fool.com)
  • This total service encompasses all of the European research services completed by the Pharmaceuticals, Biotechnology & Drug Discovery Technologies Group. (frost.com)
  • NEW YORK, NY--(Marketwire - Mar 5, 2013) - A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012. (yahoo.com)
  • We looked into changes in the drug industry and found that pharmaceutical and biotechnology sales revenue increased from $534 billion to $775 billion between 2006 and 2015. (gao.gov)
  • Last month, the Pharmaceutical Research and Manufacturers of America, which represents the pharmaceutical and biotechnology industry, launched a "Share the Savings" advertising campaign calling for public education about how the savings from rebates don't actually get passed on to commercial insurance patients. (fiercehealthcare.com)
  • To illustrate how policy may support the pharmaceutical industry at the expense of the NHS, the authors give an example of how switching patients with age-related macular degeneration from one drug to another very similar drug that is licensed for the treatment of colorectal cancer could save the NHS in England £100 million each year. (medicalnewstoday.com)
  • In 2012, doctors at Memorial Sloan-Kettering Cancer Center balked at the price of a then-new colorectal cancer drug called Zaltrap that would cost $11,000 a month. (washingtonpost.com)
  • The common solid tumours such as breast, lung, prostate and colorectal cancer are only partially responsive to drug therapy. (ddw-online.com)
  • A pharmacist counts prescription drugs at the at the CentreTown Pharmacy in Ottawa, Ontario, Canada, June 12, 2019. (reuters.com)
  • MARKET OVERVIEW Global Competitor Market Shares Nasal Drug Delivery Technology Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 2. (medindia.net)
  • The Drug & Alcohol Testing Industry Association (DATIA) is delighted to invite you to participate in DATIA's 2019 Annual Conference and Exhibition. (datia.org)
  • This event, DATIA 2019: Building a Foundation for the Future, is the ultimate confluence in critical thinking, best practices, and networking within the drug and alcohol testing industry. (datia.org)
  • WHEN A PATIENT GETS a prescription from her doctor, she shouldn't have to worry that the drug was selected because of a pharmaceutical company's marketing skills. (latimes.com)
  • Once the deal closes, Amazon could start selling prescription drugs directly through its site, delivering them via mail and affecting retail pharmacies. (businessinsider.com)
  • By banding these three self-insured employers together, Amazon may not have to rely on partners or acquisitions of pharmacy benefit managers for its roadmap into the prescription-drug business. (businessinsider.com)
  • The Canadian Life and Health Insurance Association called the regulations "a crucial step to lower prescription drug costs for all Canadians. (reuters.com)
  • Prime Minister Justin Trudeau's government is expected to announce a program to cover the cost of prescription drugs for some or all Canadians, but the program's scope is not yet clear. (reuters.com)
  • PBMs are middlemen between drug makers and consumers when it comes to purchasing drugs and providing prescription coverage. (forbes.com)
  • United BioSource appears to be less important to Express Scripts' pharmacy benefit management strategy as PBMs are looking for ways to rein in the rising costs of prescription drugs, making sure patients are getting the right medicines, in the right amount and at the right time. (forbes.com)
  • The Public Citizen Health Research Group published three books - Pills That Don't Work (1981), Over The Counter Pills That Don't Work (1983), and Worst Pills, Best Pills: A Consumer's Guide to Avoiding Drug-Induced Death or Illness (2005) - documenting hundreds of prescription and over-the-counter drugs that were not effective for their advertised purposes or had harmful side effects. (counterpunch.org)
  • With the tens of millions it spends on lobbying a year, the organization is credited with being able to sway sentiment on Capitol Hill and with the public to help get its members what they want in everything from appropriations for basic research to new provisions in the Affordable Care Act that help patients afford prescription drugs - and add dollars to their own bottom lines. (washingtonpost.com)
  • It can identify evidence of recent use of alcohol, prescription drugs and illicit drugs. (datia.org)
  • Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. (drugs.com)
  • Prescription drug prices would be controlled through the Department of Health and Human Services, and, McCaughey and Newsweek claim, would "certainly suppress research" that might benefit patients of incurable diseases and disorders. (historycommons.org)
  • The passage of the Prescription Drug User Fee Act (PDUFA) played a major role in the sharp increase in approvals. (yahoo.com)
  • WASHINGTON - Hospitals, too, are getting slammed by sharp price increases in prescription drugs, and the industry is urging the next president and Congress to take up the issue. (canadianbusiness.com)
  • The concern about the rising cost and prices of prescription drugs has been a bipartisan issue," said Rick Pollack, president of the hospital association. (canadianbusiness.com)
  • Inpatient drug spending grew more rapidly than retail prescription spending in 2014 and 2015. (canadianbusiness.com)
  • More than half of U.S. adults take prescription drugs, and according to a recent Kaiser Family Foundation poll most of those patients report no major problems affording their own medications. (canadianbusiness.com)
  • More than 3 out of 4 say the cost of prescription drugs is unreasonable. (canadianbusiness.com)
  • The UCSF_Library created this digital archive in an attempt to facilitate further research into the drug industry's practice of establishing close links with the medical community which has been shown to influence scientific research, drug approval, prescription practices, and ultimately, consumer health. (wikipedia.org)
  • The amount of money people spend on prescription drugs has nearly doubled since the 1990s. (gao.gov)
  • Retail prescription drug expenditures were estimated to account for about 12 percent of total personal health care service spending in the United States in 2015, up from about 7 percent through the 1990s. (gao.gov)
  • Experts predict that by November, the industry will have given at least $100 million to its fight against Proposition 61, which would limit the prices state agencies pay for prescription drugs. (californiahealthline.org)
  • Albany, NY -- ( SBWIRE ) -- 07/09/2015 -- The popularity of prescription drugs in ophthalmology needs no specific mention - they are quite easily the more popular medications for majority of ocular conditions. (sbwire.com)
  • We see an improving trend for FDA first cycle review approvals and a rise in the rate of new drug approvals for rare diseases, which we think is helping to boost investor sentiment for the agency, after years of criticism stemming from inconsistency in making and communicating its decisions. (yahoo.com)
  • In addition, legislation incentivizing the pharmaceutical industry to invest in therapeutics for rare diseases has been incredibly successful. (the-scientist.com)
  • But in recent years, the pharmaceutical industry has become very interested in studying rare diseases as a drug discovery strategy. (the-scientist.com)
  • Drug reps typically keep physicians up to speed on pharmaceutical pipelines and medical research, something research shows doctors don't do enough on their own. (latimes.com)
  • The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). (openpr.com)
  • Increasing R&D spending and initiatives for rare disease and orphan drugs research are set to drive the drug discovery services market. (prnewswire.com)
  • The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. (pitchengine.com)
  • Order a copy of "Prostate Cancer Treatment Drugs Industry" research report at USD 1000 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=426034 . (pitchengine.com)
  • During the same period, federal spending, which funded a greater amount of basic research relative to industry, remained stable at around $28 billion. (gao.gov)
  • Research GAO reviewed indicates that fewer competitors in the drug industry are associated with higher prices, particularly for generic drugs. (gao.gov)
  • Research also suggests that drug company mergers can have varied impacts on innovation as measured by R&D spending, patent approvals, and drug approvals. (gao.gov)
  • Instead of a regulator and a regulated industry, we now have a partnership," said Dr. Michael Carome, director of the health research group for the nonprofit advocacy organization Public Citizen, and a former U.S. Department of Health and Human Services official. (propublica.org)
  • While the long-term consequences of this are not yet fully understood, research has already shown that mixtures of drugs are disrupting the endocrine systems of fish in the United States, feminizing them, altering behavior and reproduction, changing growth, and increasing liver sizes. (bibliotecapleyades.net)
  • More than half of the respondents reported receiving travel funding or honoraria, research support, or educational programming support from the drug industry. (ashp.org)
  • IBISWorld's industry research report on Antiviral Drug Manufacturing provides up-to-date sales and market data, allowing you to identify the product and customer segments driving revenue growth. (ibisworld.com)
  • With this IBISWorld Industry Research Report on Antiviral Drug Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions. (ibisworld.com)
  • This research report categorizes the anti-Parkinson's drugs market by type. (bccresearch.com)
  • Highlights the controversy of discriminatory and unsafe research methods, discusses the drug industry, potential health effects on women, racist practices. (cwhn.ca)
  • Randall Mrsny, Ph.D., former Head of Genentech's Drug Delivery/Biology Lab, the Founder of Trinity Biosystems, the Founder and current Chief Scientific Officer of Unity Therapeutics, and Professor of Epithelial Biology at the University of Bath, UK, who will discuss his research in intracellular peptide drug delivery for epithelial-derived cancers. (prweb.com)
  • The immediate goal would be to develop a test that could identify who will have a problem with a drug before they get it," said Dr. Paul Watkins, director of the General Clinical Research Center at the University of North Carolina in Chapel Hill. (bio-medicine.org)
  • SAEC is one of several consortiums formed by the pharmaceutical industry to conduct basic research. (bio-medicine.org)
  • To sum it up, the report concludes with an all-inclusive research result on the industry chain of Drug Injection Device Sales Industry facilitating the market participants in making well-informed strategic decisions. (beforeitsnews.com)
  • ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. (webnewswire.com)
  • We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. (webnewswire.com)
  • Here's an interesting analysis of the industry from IDEA Pharma, via Endpoints. (sciencemag.org)
  • Amid the COVID-19 crisis, the global market for Implantable Drug Delivery Devices estimated at US$20 Billion in the year 2020, is projected to reach a revised size of US$30.2 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. (reportlinker.com)
  • The report also covers market value projections, market attractiveness analysis, and key market share analysis in the market overview section in order to provide a thorough analysis of the overall competitive scenario of the global benzodiazepine drugs market. (prnewswire.com)
  • The global alcohol breathalyzer and drug testing equipment market is presented in a statistical and explanatory format, where analysis of each factor in the market is discussed in terms of their future repercussions. (sbwire.com)
  • This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global drug delivery systems market. (bccresearch.com)
  • The analysis in the Drug Injection Device Sales Industry report is of a two-fold perspective, production and sales. (beforeitsnews.com)
  • Furthermore, the report talks about the complete analysis of the raw materials as well as demand and supply of the Onychomycosis (Tinea Unguium) Drug. (beforeitsnews.com)
  • Biologics-drugs derived from living rather than chemical sources-and orphan drugs accounted for growing shares of drug approvals, reflecting market and policy incentives to invest in these areas, according to experts GAO interviewed. (gao.gov)
  • The burgeoning market for biologics and gene-based products, which by their very nature are difficult to administer, represents an emerging opportunity for the drug delivery industry. (prweb.com)
  • Attendees will come away from this conference with a better understanding the clinical, regulatory, legal and commercial issues facing novel drug delivery technologies and their application in biologics and targeted therapies. (prweb.com)
  • This is a driving factor for the growth of the global unfractionated heparin drug market. (mynewsdesk.com)
  • Much of this growth was driven by use of expensive brand-name drugs, but price increases have been reported for some generic drugs as well. (gao.gov)
  • The primary reason for the growth of the global alcohol breathalyzer and drug testing equipment market is the growing consumption of alcohol and other intoxicating substances across the world. (sbwire.com)
  • Another factor promoting the growth of the global alcohol breathalyzer and drug testing equipment market is the growing demand for portable breathalyzers. (sbwire.com)
  • However, the market also has its own set of problems that may have a negative impact on its growth, namely the lack of awareness amongst the population about the benefits of early diagnosis, the lack of new formulations in the market, and patent expiry of some major drugs in the market. (sbwire.com)
  • Amongst these, the segment of anti-glaucoma drugs currently has the major shares of demand and is also expected to observe market growth at the fastest pace in the coming years. (sbwire.com)
  • The huge base of population in Asian countries such as China and India, a large share of which is getting old, is the major reason behind the enormous growth potential provided by this region for the ophthalmic drugs industry. (sbwire.com)
  • Presently, the global ophthalmic drugs market is experiencing good growth, albeit it remains constrained due to the lack of new formulas in the market. (sbwire.com)
  • They also have a role in viral entry, tumour growth, and metastasis, and as such, have received significant attention from the pharmaceutical industry. (diamond.ac.uk)
  • But for orphan drugs with limited commercial potential, the ability to use surrogate endpoints is essential to getting the clinical trials done quickly and cheaply. (fool.com)
  • They're looking at the revenues from the more recent drugs in the pipeline (approved in the last five years) and comparing that to each company's total R&D spending. (sciencemag.org)
  • The event also included a panel that offered an overview of specialty pharmacy, including current trends in the industry, a review of the drug pipeline and discussions about financial models, stakeholder expectations and other issues. (drugstorenews.com)
  • The firm also has 30 generic products in its pipeline and 12 abbreviated new drug applications (ANDAs) pending at the FDA. (fdanews.com)
  • the PR campaign they've created is called "The Ethics, the Urgency and the Potential," and its premise is that it is "unethical not to use the drug. (slate.com)
  • There is a lot of merit to the Merck proposal,'' said a spokeswoman for another leading drug maker, who asked not to be identified. (nytimes.com)
  • Several Medicaid drug bills, including one that would strengthen Medi-Cal's leverage in bargaining for discounts and one supporting the Merck approach, have been introduced in the Legislature. (nytimes.com)
  • John L. Zabriskie, president of Merck Sharp & Dohme, Merck's drug-making unit, said that four states - Arkansas, Delaware, Utah and South Carolina - had indicated that they would accept Merck's offer. (nytimes.com)
  • For example, the drug Vioxx, sold by Merck &Co., Inc., as an anti-inflammatory drug, stayed on the market from 1999 to 2004 despite documented cardiovascular risks. (counterpunch.org)
  • That's O.K. for something like Merck 's (NYSE: MRK) anacetrapib, where the FDA is requiring clinical outcomes -- heart attacks, strokes, and the like -- rather than just demonstrating that the drug lowers bad cholesterol and raises the good kind. (fool.com)
  • Now hospitals are turning up the volume as well, leaving the pharmaceutical industry more politically isolated. (canadianbusiness.com)
  • PHARMACEUTICAL company executives are watching nervously as drug prices come under growing criticism in Congress and states that are scrimping to pay for Medicaid programs for the poor. (nytimes.com)
  • To get the discounts, Medicaid programs would have to accept all company products, exempting them from restrictions that currently exclude some expensive drugs. (nytimes.com)
  • So when a drug company gives money to bioethicists, it's a little like giving money to the poor. (slate.com)
  • If the drug company makes no effort to influence your work, is there anything wrong with taking their money? (slate.com)
  • Often, when a drug company is launching a new drug, it recruits a third party known as a Key Opinion Leader: an influential figure respected by his or her peers and often eagerly sought out by the press. (slate.com)
  • The rules will save money for patients, employers and insurers including the government at the expense of drug company profits. (reuters.com)
  • Mollie Shields-Uehling, chief executive of the US-based Safe Biopharma Association, says, "For each new drug application, there are between one million and six million pages of paper that have to be saved by the company and stored for the life of the drug, plus some significant amount of time after the drug comes off the market. (computerweekly.com)
  • A former hedge fund manager, Shkreli has become the public face of the pricing controversy, after his company raised the price of the anti-infection drug Daraprim by more than 5,000 percent. (denverpost.com)
  • Despite frequent exposure of misdeeds, the army of drug company lobbyists in Washington continues to gain political influence and rake in corporate welfare at the expense of taxpayers. (counterpunch.org)
  • The cause of competition was not helped when the drug company lobbyists used their campaign contributions and influence on Congress in 2003 to brazenly prohibit Uncle Sam from negotiating prices for the gigantic Medicare drug benefit program. (counterpunch.org)
  • The secret truth, however: Shkreli is far from the only drug company executive to set what critics say are exorbitant prices, and he certainly won't be the last. (washingtonpost.com)
  • Abbott's drugs business is, however, solely focused on providing affordable generic medicines in emerging markets, as the company does not sell medicine in the US, Europe or other developed markets, the spokesperson highlighted. (euractiv.com)
  • The company and GlaxoSmithKline plc recently reported that the FDA has accepted its New Drug Application for ANORO ELLIPTA for patients with chronic obstructive pulmonary disease. (yahoo.com)
  • The archive contains documents about pharmaceutical industry clinical trials, publication of study results, pricing, marketing, relations with physicians and drug company involvement in continuing medical education. (wikipedia.org)
  • Many physicians are skeptical of statins' perceived benefits, particulalry because the study was funded by the drug company Astra-Zeneca, the maker of the statin drug used in the trial. (mercola.com)
  • A survey of clinical trials revealed that when a drug company funds a study , there is a 90 percent chance that the drug will be perceived as effective whereas a non-drug-company-funded study will show favorable results just 50 percent of the time. (mercola.com)
  • Line graph showing drug company profit margins nearing 20 percent. (gao.gov)
  • A survey of clinical practice guideline authors revealed that 87% had a financial relationship with at least one drug company. (ashp.org)
  • A subset of nearly 70 guideline authors offered their opinion of how the relationship with a drug company influenced the guideline-creation process. (ashp.org)
  • PITTSBURGH A news article published over the weekend calling generic drug maker Mylan's manufacturing into question has drawn a response from the company. (drugstorenews.com)
  • International generic drug company Actavis Group is expanding into the U.S. market through the purchase of privately held U.S. generic firm Amide Pharmaceutical. (fdanews.com)
  • Ed Maggio, Ph.D., CEO of Aegis Therapeutics, a company focused on the commercialization of both advanced patented drug delivery, and protein stabilization technologies. (prweb.com)
  • It is one of the best-selling drugs in the world, generating billions of dollars of income every year, and yet, according to the journal, the drug company anticipated initial annual sales of just £100,000. (healthy.net)
  • This seems hard to believe, as it would have taken the drug company 500 years to recoup the licensing costs alone, and before any marketing costs. (healthy.net)
  • Last year, executives at Mylan, the maker of the EpiPen, said the list price of the drug for life-threatening allergic reactions was $600, but the company earned $274 after rebates and other fees. (fiercehealthcare.com)
  • The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints, opportunities and key trends that influence the current and future status of the benzodiazepine drugs market. (prnewswire.com)
  • Our clients rely on our information and data to stay up-to-date on industry trends across all industries. (ibisworld.com)
  • Stay up to date as our experts talk about the latest industry trends, community initiatives, events and news. (westpharma.com)
  • The PBM's role is in part to leverage its negotiating clout to get the best drug prices on behalf of its diverse base of customers that include large employers as well as Medicare and Medicaid. (forbes.com)
  • Hospitals say they can't easily pass on the cost of pricey drugs because private insurers and government programs like Medicare usually pay a pre-determined amount per case. (canadianbusiness.com)
  • A new JAMA study examines how drug rebates can direct money to middlemen and force Medicare patients to cough up more money. (fiercehealthcare.com)
  • The paper, which dives into the complex and opaque world of Medicare drug price negotiations, finds that rebates may actually drive up the amount Medicare and its beneficiaries pay for drugs-especially for increasingly common high-priced drugs-and it offers some systemic solutions. (fiercehealthcare.com)
  • Trump's administration has said it wants to lower drug prices and hinted at mandating rebates in Medicare. (fiercehealthcare.com)
  • And, even though patients don't pay list prices for their drugs, those high prices (like $600 for the EpiPen) are used to calculate how much Medicare covers for any individual patient-and sometimes what patients pay out-of-pocket, Dusetzina said. (fiercehealthcare.com)
  • Bach called the current Medicare system "absolutely devastating for people on high-cost specialty drugs. (fiercehealthcare.com)
  • This solution comes, in part, because the number of Medicare enrollees paying coinsurance for their drug, rather than a flat fee, has increased to 58% last year from 35% in 2014, the paper notes. (fiercehealthcare.com)
  • This report analyzes the worldwide markets for Anemia Drugs in US$ Million by the following segments: Short Acting ESAs (Erythropoiesis Stimulating Agents), and Long Acting ESAs (Erythropoiesis Stimulating Agents). (medindia.net)
  • However, concentration was higher for narrower markets, such as for certain drugs in the same therapeutic class. (gao.gov)
  • McBride also argued that adopting final regulations without a blanket exclusion for convicted drug traffickers will attract unwanted attention from the federal Department of Justice, which earlier this year rescinded an Obama-era policy that essentially directed federal prosecutors to look the other way in states that have established legal marijuana markets. (wbjournal.com)
  • Asia, as for many other industries, represents one of the major markets for this industry in the near future. (sbwire.com)
  • So if we are talking about a complete deconstruction of the model - we could inadvertently create a pathway to strengthen the illegal markets largely controlled by the cartels," said Kristi Kelly, executive director of the Colorado based Marijuana Industry Group. (wkbw.com)
  • We provide our services to all sizes of organizations and across all industry verticals and markets. (webnewswire.com)
  • The ease of portability of these machines, along with their lowering prices, is creating a higher demand in the global alcohol breathalyzer and drug testing equipment market. (sbwire.com)
  • During 2005-2013, sales of recombinant protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%, and it is projected that China will see its actual demand for recombinant protein drugs exceed RMB40 billion in 2014. (prweb.com)
  • China recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. (prweb.com)
  • As someone who works in the drug discovery labs, I'm just as guilty as everyone else: twenty years in the labs, and I've never worked on anything that's on a pharmacy shelf. (theatlantic.com)
  • Aspirin, acetominophen, and penicillin wouldn't have made it through a modern drug discovery effort. (theatlantic.com)
  • We're seeing a lot of bivalent molecules in drug discovery these days, especially with the popularity of bifunctional protein degrader ligands. (sciencemag.org)
  • I have an anniversary to celebrate this time of year: it's now been thirty years since I started work in industrial drug discovery. (sciencemag.org)
  • By process, the Hit-to-Lead process accounted for the fastest-growing segment of the drug discovery service market. (prnewswire.com)
  • By type, the Medicinal Chemistry segment accounted for the largest share of the drug discovery service market. (prnewswire.com)
  • Based on type, the drug discovery services market is segmented into medicinal chemistry services, biology services, and drug metabolism and pharmacokinetics (DMPK). (prnewswire.com)
  • The medicinal chemistry services segment is estimated to account for the largest share of the drug discovery services market due to the widespread application of medicinal chemistry in various phases of preclinical drug discovery to deliver robust candidates. (prnewswire.com)
  • Based on the therapeutic area, the drug discovery services market is segmented into oncology, cardiovascular diseases, neurology, infectious and immune system diseases, digestive system diseases, and other therapeutic areas. (prnewswire.com)
  • The fastest-growing region in the drug discovery services market. (prnewswire.com)
  • The largest share of the drug discovery services market. (prnewswire.com)
  • Used by all living things to make proteins, messenger RNA is one of the least explored frontiers of drug discovery. (acs.org)
  • This paper in Nature Reviews Drug Discovery has some numbers. (sciencemag.org)
  • These are worrying times', warn the editors of Nature Reviews Drug Discovery, a medical journal. (healthy.net)
  • studies have shown that even small gifts increase doctors' sense of obligation to pharmaceutical makers, especially free drug samples that clearly sway decisions to stick with expensive medications that often aren't any more effective than cheaper competitors. (latimes.com)
  • Makers of such drugs would have to bid against each other. (nytimes.com)
  • Because of mergers and reorganizations in the chemical and pharmaceutical industries, the makers of the quit-smoking products say their marketing is now free of tobacco industry influence. (nytimes.com)
  • ReportLinker simplifies how Analysts and Decision Makers get industry data for their business. (reportlinker.com)
  • Bloomberg recently reported drug approvals by the U.S. Food and Drug Administration reached a 15 year high in 2012. (yahoo.com)
  • Novel drugs-innovative products that serve previously unmet medical need or help advance patient care-accounted for about 13 percent of all approvals each year. (gao.gov)
  • While the FDA over the past three decades has implemented at least four major routes to faster approvals - the current commissioner, Dr. Scott Gottlieb, is easing even more drugs' path to market. (propublica.org)
  • Should promising cancer drugs like Seattle Genetics ' (Nasdaq: SGEN) Adcetris not get accelerated approvals based on progression-free survival or response rate because the surrogate endpoints doesn't always correlate with overall survival? (fool.com)
  • Which of these drugs will have the highest peak sales at the highest CAGR, and why? (medgadget.com)
  • Unfractionated heparin drug is an anticoagulant drug. (mynewsdesk.com)
  • Because the event is hosted by DATIA, the leading association involved in shaping and developing the industry for over 23 years, attendees are assured that the speakers, seminars, educational content, and networking events will be highly rewarding. (datia.org)
  • For those new to drug and alcohol testing or looking for a primer, DATIA recommends taking the Ins & Outs of Drug & Alcohol Testing online course prior to taking this course. (datia.org)
  • The news sent a whole host of pharmaceutical and drug-wholesaler stocks tumbling . (businessinsider.com)
  • I want to get the latest chemistry news from C&EN in my inbox every week. (acs.org)
  • Get all the latest industry news in your inbox. (drugstorenews.com)
  • Nanowerk News ) Following the U.S. Food and Drug Administration's recent decision to participate in the inspection of overseas drug-manufacturing facilities, the pharmaceutical industry is reexamining its approach to quality control. (nanowerk.com)
  • Access our premium content, receive daily and weekly news updates in addition to our industry-valued newsletters. (agri-pulse.com)
  • The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry's value chain. (openpr.com)
  • Join your colleagues and industry experts for the industry's premier educational event.With Over 600 attendees, 65 exhibitors, 25 educational sessions, and pre- and post-conference trainings this is your one-stop shop for staying current on what's happening in the drug and alcohol testing industry. (tsnn.com)
  • This paper examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of minimum efficacy standards and price control mechanisms (MES+PC). (nber.org)
  • Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals and as a result it improves drug efficacy by controlling rate and time of release of drug. (bccresearch.com)
  • But then it flipped 13-4 in the other direction, voting that the drug does provide efficacy for a surrogate endpoint that is reasonably likely to predict a clinical benefit. (fool.com)
  • Combination drugs also have advantages over traditional medicines such as reduced need for drug application, improved efficacy and patient compliance. (sbwire.com)
  • Based on delivery systems type the global drug delivery systems market is segmented into intrauterine implants, prodrug implants, polymeric drug delivery, and targeted drug delivery. (bccresearch.com)
  • In the future, the dynamics of the lucrative moderate to severe UC market will shift greatly from the historical strategy of developing biologic drugs, towards small molecule oral drugs. (medgadget.com)
  • Well, considering that any institution which developed and marketed a drug would immediately become part of the pharmeceutical industry by definition, your request for a list is rather self-serving. (bio.net)
  • By the way, the drug industry is required by law to fund a large portion of the FDA's drug review budget, which contributes to this weak regulatory oversight. (counterpunch.org)
  • In an essay published by the Journal of the Royal Society of Medicine , health economists Professor Alan Maynard and Professor Karen Bloor describe an inflationary regulatory system that lacks accountability, is not evidence-based and subverts the efficiency of the technology appraisal work carried out by NICE, a target of pharmaceutical industry hostility since it was established in 1999. (medicalnewstoday.com)
  • Professionals, from industry service providers to end-user clients, will be in attendance to learn and discuss the very latest information on regulatory affairs, ethics, safety, and the business practices critical to their organization's outlook. (datia.org)
  • Once widely assailed for moving slowly, today the FDA reviews and approves drugs faster than any other regulatory agency in the world. (propublica.org)
  • Regulatory agencies rely on such industry funded studies for surveillance of drug safety. (bmj.com)
  • The anticonvulsants drug market has been segmented based on therapeutic class, disease indication, formulation, distribution channel, and region. (openpr.com)
  • Of the major anticonvulsant drugs currently marketed, Lyrica (pregabalin), Neurontin (gabapentin), Topamax (topiramate), Depakote (divalproex), and Carbatrol/Tegretol (carbamazepine) are indicated for management of various types of pain. (openpr.com)
  • Frost & Sullivan offers total market subscriptions for each of the major industry sectors. (frost.com)
  • It also analyzed drug purchase costs for 28 drugs from two major group purchasing organizations, which allow hospitals to maximize volume discounts for commonly used supplies. (canadianbusiness.com)
  • A major portion of the global alcohol breathalyzer and drug testing equipment market finds use in the field of law enforcement and highway safety administrations. (sbwire.com)
  • For the ease of understanding, the global market of ophthalmic drugs can be generally segmented in three major divisions - drugs according to treatments, drugs according to types and the major geographic regions of importance for this industry. (sbwire.com)
  • Taylor sees little chance that the industry will reverse these major initiatives. (agri-pulse.com)
  • It properly analyzes the world's major regions market conditions and helps the established players as well as the new entrants with a comprehensive insight of the current situation in the Onychomycosis (Tinea Unguium) Drug industry. (beforeitsnews.com)
  • In order to prepare the report, all the important details, strategies and variables are studied so that all the useful information is blended together for the purpose of the study and understanding the major facts about the Global Onychomycosis (Tinea Unguium) Drug Industry. (beforeitsnews.com)
  • Valeant is already under investigation by several members of Congress for its general business strategy, which involves buying smaller drug developers and then jacking up the prices of their medicines. (denverpost.com)
  • In Rhode Island, where the district he represented in Congress is located, drug overdoses are a public health crisis . (yahoo.com)
  • Dr. Angell charges that the industry is "primarily a marketing machine to sell drugs of dubious benefits, using its wealth and power to co-opt every institution that might stand in its way, including the U.S. Congress, the Food and Drug Administration, academic medical centers and the medical profession itself. (counterpunch.org)
  • The paper's findings and proposed solutions come as President Donald Trump's administration, Congress and state lawmakers grapple with ways to control drug prices and overall health spending. (fiercehealthcare.com)
  • Avista's commitment to the healthcare industry makes them the ideal partner as we continue to improve patient care," Lindsay said. (forbes.com)
  • Global Sports Medicine Market Report: 2015 Edition (http://www.marketreportsonline.com/425988.html) The global sports medicine market is a very dynamic sector that has made a mark in the healthcare industry in the last decade. (pitchengine.com)
  • This report analyzes the Global market for Liver Cancer Drugs in US$ Million. (fiercepharma.com)
  • Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. (mynewsdesk.com)
  • Not only will it give you an overview of the drug and alcohol testing industry, but it will also serve as a pre-requisite for DATIA's more advanced courses. (datia.org)
  • The report is broadly divided into six parts and each part focus upon the industry overview, condition of the Onychomycosis (Tinea Unguium) Drug Industry, the investment feasibility as well as various policies and strategies. (beforeitsnews.com)
  • The report begins with the Onychomycosis (Tinea Unguium) Drug Industry Overview which is based upon by the classifications, specifications, modifications. (beforeitsnews.com)
  • Lilly had hoped that Xigris would be its new blockbuster, but the drug hasn't taken off. (slate.com)
  • Since all the other molecules are generic and have negligible contribution in the pain management application, the market will be driven and dominated by the sales of existing blockbuster drug Lyrica, which constituted 73.4% share of the total market in 2011. (openpr.com)
  • This document was developed as a special control to support the classification of drug metabolizing enzyme (DME) genotyping systems into class II (special controls). (fda.gov)
  • Ultrasound technology is an area of increasing application in the food, drug, and device industries. (fda.gov)
  • This ITG serves as an introductory issue for future ITGs that will describe specific applications of ultrasound in the food, drug, and medical device industries. (fda.gov)
  • The Food and Drug Administration approved the pill in December. (npr.org)
  • The company's lead program, ADCETRIS, received accelerated approval from the U.S. Food and Drug Administration in August 2011 and approval with conditions from Health Canada in February 2013 for two indications. (yahoo.com)
  • Nevertheless, the U.S. Food and Drug Administration approved both of these drugs - with a deadly aftermath. (propublica.org)
  • Published in the scientific journal Nature Communications , the study ( A Diverse Suite of Pharmaceuticals Contaminates Stream and Riparian Food webs ) adds to growing evidence that the pharmaceutical industry is having a dangerous impact on food chains, water supplies, and the environment. (bibliotecapleyades.net)
  • Noting that people who eat fish are also potentially affected, the study is the first of its kind to show that such a wide range of pharmaceutical drugs has infiltrated food chains. (bibliotecapleyades.net)
  • Written comments and suggestions may be submitted at any time for Agency consideration to the Division of Dockets Management, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD, 20852. (fda.gov)
  • A manufacturer who intends to market a device of this type should (1) conform to the general controls of the Federal Food, Drug, and Cosmetic Act (the Act), including the premarket notification requirements described in 21 CFR 807 Subpart E, (2) address the specific risks to health associated with DME genotyping systems identified in this guidance, and (3) obtain a substantial equivalence determination from FDA prior to marketing the device. (fda.gov)
  • WASHINGTON Policy Solutions, a new government and public affairs firm, has opened a practice in Washington, led by three food industry veterans. (drugstorenews.com)
  • Recently, the US Food and Drug Administration and European Medicines Agency have issued new guidance for industry on drug interaction studies, which outline comprehensive recommendations on a broad range of in vitro and in vivo studies to evaluate drug-drug interaction (DDI) potential. (nih.gov)
  • The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Vulvovaginal Candidiasis: Developing Drugs for Treatment. (federalregister.gov)
  • The two drug reactions that are being studied, Stevens-Johnson and liver toxicity, are very common reasons for problems with drugs either being restricted, not being developed, not being approved or being pulled off the market," said Dr. Janet Woodcock, Deputy Commissioner and Chief Medical Officer at the U.S. Food and Drug Administration. (bio-medicine.org)
  • For more on drug safety and side effects, visit the U.S. Food and Drug Administration . (bio-medicine.org)
  • We are taking the biggest step in a generation to lower the price of drugs in Canada by moving forward with these regulations," Minister of Health Ginette Petitpas Taylor said in an interview. (reuters.com)
  • The new features of the regulations, which take into account cost-effectiveness of medicines and their impact on government budgets, apply only to drugs approved by Health Canada after the rules are officially published later this month. (reuters.com)
  • Generally, most private employers have a fair amount of latitude in implementing drug testing as they see fit for their organization, unless they are subject to certain Federal regulations, such as the U.S. Department of Transportation's (DOT) drug-testing rules for employees in safety-sensitive positions. (datia.org)
  • DOT's alcohol and drug-testing regulations require all tests be performed using a "split sample" collection process. (datia.org)
  • The Implantable Drug Delivery Devices market in the U.S. is estimated at US$5.9 Billion in the year 2020. (reportlinker.com)
  • A segment of the opioid medication market deals with getting people hooked on opioids off those drugs. (healthline.com)
  • Each segment takes up a different proportion of the global alcohol breathalyzer and drug testing equipment market, owing to their usefulness, accuracy of reading, ease of use, and cost of equipment. (sbwire.com)
  • The type of delivery system segment have been analyzed based on type of devices used to deliver drugs for different applications in various regions. (bccresearch.com)
  • Kennedy argues that lack of regulation in the pharmaceutical and alcohol industries is a prime example of why marijuana could be just as dangerous if legalized. (yahoo.com)
  • Regulation of the pharmaceutical industry: promoting health or protecting wealth? (medicalnewstoday.com)
  • He was participating in some industry clinical trials, but the route to helping patients wasn't direct enough. (sciencemag.org)
  • In clinical trials, rescue medicines are given with a drug to control the alleviated symptoms of the study treatment or lack of disease efficiency. (openpr.com)
  • Nuplazid, a drug for hallucinations and delusions associated with Parkinson's disease, failed two clinical trials. (propublica.org)
  • Fake medicines often contain the wrong or toxic ingredients and pose a growing health threat worldwide, especially in poor countries where drugs are sold to treat conditions such as malaria, tuberculosis and HIV. (reuters.com)
  • If Novartis wins, even older medicines could be subject to patenting again, and it will become much more difficult for us in future to provide medicines to our patients being treated for HIV, hepatitis and drug resistant TB. (law.com)
  • With the aged tendency of population in China and the increasing morbidity of chronic diseases which have to be treated with medicines for the rest of patients life, market scale of cardiovascular drugs is expanding. (pitchengine.com)
  • Drug rescue is also termed as rescue medicines. (openpr.com)
  • Drug which is given to counter or block the effect of other medicines are called as rescue medicines. (openpr.com)
  • Ibuprofen or acetaminophen or drugs containing caffeine are the most common rescue medicines for migraine. (openpr.com)
  • Asia Pacific is the most progressive region for the drug rescue market due to increasing over-the-counter rescue medicines in the region. (openpr.com)
  • However, the increasing side effects of rescue medicines is likely to restrain the drug rescue market. (openpr.com)
  • As an industry we remain committed to working with all partners to continue to advance global health, improving access to medicines and the capacity and sustainability of healthcare systems," the EFPIA source concluded. (euractiv.com)
  • Between 2011 and 2015, the FDA reviewed new drug applications more than 60 days faster on average than did the European Medicines Agency. (propublica.org)
  • The public health doesn't stand a chance in this fight, because we're up against money that is going to continue to grow as this industry spreads," Kennedy concedes, likening marijuana proponents to the big tobacco industry. (yahoo.com)
  • Given the rapidly changing industry dynamics, some observers believe Express Scripts will be forced to sell to a larger player, especially if the now month-old rumor of CVS Health merging with Aetna becomes a reality. (forbes.com)
  • Other so-called "break-through" drugs are costing patients over $100,000 each a year and driving frantic health insurers and Medicaid managers up the wall. (counterpunch.org)
  • Professors Maynard and Bloor, of the Department of Health Sciences at the University of York, point to the evaluation of end-of-life products such as cancer drugs. (medicalnewstoday.com)
  • The decision to move to industry was born of a desire to work someplace "where the focus was still very much on the science but there was still a likelihood that my work will have an impact on human health within my lifetime," he says. (sciencemag.org)
  • The BMJ has evidence that unlicensed employees from several Indian drug firms and from the Indian arms of Abbott, Bayer, GlaxoSmithKline, Roche, and Sanofi have tested patients at health camps. (eurekalert.org)
  • This kind of behavior can actually lead to harm to patients -- overdiagnosis, misclassification [of healthy people as sick], iatrogenic harm of drugs," Glyn Elwyn, a primary care clinician-researcher at The Dartmouth Center for Health Care Delivery Science in Hanover, New Hampshire, USA, told The BMJ. (eurekalert.org)
  • Alcohol and drug abuse creates significant safety and health hazards and can result in decreased productivity and poor employee morale. (datia.org)
  • However, Federal agencies conducting drug testing must follow standardized procedures established by the Substance Abuse and Mental Health Services Administration (SAMHSA), part of the U.S. Department of Health and Human Services (DHHS). (datia.org)
  • The most common method of drug testing, urinalysis, can be done at the workplace (at a health unit, for example), a doctor's office or any other site selected by the employer. (datia.org)
  • According to EFPIA, the report completely fails to recognise the unique and important role played by the industry in delivering better health for millions of people across the world, transforming the outlook for patients living with serious, debilitating and sometimes fatal illnesses diseases like HIV, cancer, diabetes, cardiovascular disease, and hepatitis C. (euractiv.com)
  • That relationship has tilted the agency away from a public health perspective to an industry friendly perspective. (propublica.org)
  • This illustrates yet another reason why we need to replace drug-based disease-care medicine with a truly preventive system of healthcare that utilizes safe, non-toxic, science-based natural health approaches. (bibliotecapleyades.net)
  • Visit West's booth to learn more about our vial containment systems and how packaging affects patients' health, operational efficiency, drug compatibility and drug stability. (westpharma.com)
  • How these rebates and price concessions happen between the manufacturer of the drug and the PBMs [pharmacy benefit managers] and health plans can directly impact patient cost in a big way," said the paper's lead author, Stacie Dusetzina of the University of North Carolina-Chapel Hill's pharmacy school. (fiercehealthcare.com)
  • The authors suggest that incentives for health insurers need to change to require health plans to pay more of the drugs' costs after beneficiaries pass through the doughnut hole. (fiercehealthcare.com)
  • The only thing voluntary about it was the alignment around the goal that the industry and producers both realized needed to be achieved, which was that you've got to move past this ancient, anti-public health technology to a place that is better, that consumers will accept. (agri-pulse.com)
  • It is the singular place where hundreds of drug and alcohol testing industry professionals from all over the world meet to partake in well-crafted educational sessions and to learn about new product launches and service offerings. (datia.org)
  • Personally, I find that any industry which would kill people for profits is not generally under consideration for my 'most ethical industries' list. (bio.net)